The invention relates generally to devices, systems, and methods for the delivery and implantation of a prosthesis to a targeted site within the body, e.g., for the repair of diseased and/or damaged sections of a hollow body organ and/or blood vessel.
The weakening of a vessel wall from damage or disease can lead to vessel dilatation and the formation of an aneurysm. Left untreated, an aneurysm can grow in size and may eventually rupture.
For example, aneurysms of the aorta primarily occur in the abdominal region, usually in the infrarenal area between the renal arteries and the aortic bifurcation. Aneurysms can also occur in the thoracic region between the aortic arch and renal arteries. The rupture of an aortic aneurysm results in massive hemorrhaging and has a high rate of mortality.
Open surgical replacement of a diseased or damaged section of vessel can eliminate the risk of vessel rupture. In this procedure, the diseased or damaged section of vessel is removed and a prosthetic prosthesis, made either in a straight or bifurcated configuration, is installed and then permanently attached and sealed to the ends of the native vessel by suture. The prosthetic prosthesis for these procedures are usually unsupported woven tubes and are typically made from polyester, ePTFE or other suitable materials. The prosthesis are longitudinally unsupported so they can accommodate changes in the morphology of the aneurysm and native vessel. However, these procedures require a large surgical incision and have a high rate of morbidity and mortality. In addition, many patients are unsuitable for this type of major surgery due to other co-morbidities.
Endovascular aneurysm repair has been introduced to overcome the problems associated with open surgical repair. The aneurysm is bridged with a vascular prosthesis, which is placed intraluminally. Typically these prosthetic prostheses for aortic aneurysms are delivered collapsed on a catheter through the femoral artery. These prostheses are usually designed with a fabric material attached to a metallic scaffolding (stent) structure, which expands or is expanded to contact the internal diameter of the vessel. Unlike open surgical aneurysm repair, intraluminally deployed prostheses are not sutured to the native vessel, but rely on either barbs extending from the stent, which penetrate into the native vessel during deployment, or the radial expansion force of the stent itself is utilized to hold the prosthesis in position. These prosthesis attachment means do not provide the same level of attachment when compared to suture and can damage the native vessel upon deployment.
Accordingly, there is a need for improved prosthesis delivery devices, systems, and methods that deliver a prosthetic graft to a body lumen, the prosthesis being able to adapt to changes in aneurysm morphology and able to be deployed safely and without damage to the native vessel.
The devices, systems, and methods for delivering and implanting radially expandable prostheses in the body lumens are described. In particular, the present invention provides improved devices, systems, and methods for implanting vascular prostheses into blood vessels, including both arterial and venous systems. In the exemplary embodiments, prostheses are placed in vasculature to reinforce aneurysms, particularly abdominal aortic aneurysms.
One aspect of the invention provides devices, systems, and methods for fastening a prosthesis into a hollow body organ or blood vessel. The devices, systems, and methods include a fastener applier that is sized and configured for securing a prosthesis, the fastener applier comprising a handle assembly positioned at the caudal end of the fastener applier, a fastener applier shaft coupled to the handle assembly, and a fastener driver for advancing a fastener into the prosthesis and tissue, the fastener driver coupled to the fastener applier shaft at the cephalad end of the fastener applier shaft, the fastener driver including a housing and a release latch, wherein the release latch prevents premature release of the fastener from the fastener driver. The fastener driver housing may also include an internally threaded portion and a non-threaded portion, the non-threaded portion providing an area where the fastener can be rotated but not advanced out of the driver, the advancement out of the driver only taking place if the fastener has been previously engaged in tissue or the prosthesis.
In one embodiment, the handle assembly may further include a motion control assembly to be used by an operator, the motion control assembly providing motion control of the fastener within the fastener driver. The motion control assembly may include a forward control function and a reverse control function. The handle assembly may also include an indication assembly to provide information to an operator, the indication assembly providing at least one of an audible and visual indication. The information provided may include at least one of a fastener position or timing or status or error, or any combination.
In one embodiment, fastener is a helical fastener. The helical fastener may include a fastener body having a distal end for penetrating tissue in response to a force and a proximal end for releasably coupling the fastener body to the fastener applier, and a stop structure associated with the proximal end to prevent over-penetration of the fastener body into tissue, the stop structure bisecting the diameter of the fastener body. The stop structure may be offset from the diameter of the fastener body.
An additional aspect of the invention provides devices, systems, and methods for storing a fastener used for securing a prosthesis into a hollow body organ or blood vessel. The devices, systems, and methods comprise a base structure, and at least one receptacle positioned within the base structure, the receptacle sized and configured to releasably store at least one fastener. The receptacle may be sized and configured to releasably store at least one helical fastener. The helical fastener may include a fastener body having a distal end for penetrating tissue in response to a force and a proximal end for releasably coupling the fastener body to the fastener applier, and a stop structure associated with the proximal end to prevent over-penetration of the fastener body into tissue, the stop structure bisecting the diameter of the fastener body. The stop structure may be offset from the diameter of the fastener body.
In one embodiment the receptacle is sized and configured to present the fastener to a fastener applier. There may also be a post positioned within the receptacle to releasably restrain the fastener. A pliable material may also be included within the receptacle to position a tip of the fastener in the pliable material to releasably restrain the fastener. The fastener may also be releasably restrained within the receptacle by friction between the fastener and the receptacle wall.
Yet an additional aspect of the invention provides devices, systems, and methods for installing a fastener to a fastener applier used for securing a prosthesis in to a hollow body organ or blood vessel. The devices, systems, and methods comprise providing an apparatus for storing a fastener, the apparatus comprising a base structure, and at least one receptacle positioned within the base structure, the receptacle sized and configured to releasably store at least one fastener, providing a fastener applier for securing a prosthesis, the fastener applier comprising a handle assembly positioned at the caudal end of the fastener applier, a fastener applier shaft coupled to the handle assembly, and a fastener driver for advancing a fastener into the prosthesis and tissue, the fastener driver coupled to the fastener applier shaft at the cephalad end of the fastener applier shaft, the fastener driver including a housing and a release latch, wherein the release latch prevents premature release of the fastener from the fastener driver, positioning the fastener driver so as to allow the fastener driver to couple to releasably stored fastener, and coupling the fastener to the fastener applier. The step of coupling the fastener to the fastener applier may also include operating a motion control assembly positioned on the handle assembly to retract the fastener out of the receptacle and onto the fastener driver.
In one embodiment, the receptacle is sized and configured to releasably secure at least one helical fastener. The helical fastener may include a fastener body having a distal end for penetrating tissue in response to a force and a proximal end for releasably coupling the fastener body to the fastener applier, and a stop structure associated with the proximal end to prevent over-penetration of the fastener body into tissue, the stop structure bisecting the diameter of the fastener body. The stop structure may be offset from the diameter of the fastener body.
Other features and advantages of the invention shall be apparent based upon the accompanying description, drawings, and claims.
This Specification discloses various catheter-based devices, systems, and methods for delivering and implanting radially expandable prostheses in the body lumens. For example, the various aspects of the invention have application in procedures requiring the repair of diseased and/or damaged sections of a hollow body organ and/or blood vessel. The devices, systems, and methods that embody features of the invention are also adaptable for use with systems and surgical techniques that are not necessarily catheter-based.
The devices, systems, and methods are particularly well suited for treating aneurysms of the aorta that primarily occur in the abdominal region, usually in the infrarenal area between the renal arteries and the aortic bifurcation, as well as aneurysms that also occur in the thoracic region between the aortic arch and renal arteries. For this reason, the devices, systems, and methods will be described in this context. Still, it should be appreciated that the disclosed devices, systems, and methods are applicable for use in treating other dysfunctions elsewhere in the body, which are not necessarily aorta-related.
I. Overview
In order to provide a consistent orientation for the devices, systems, and methods described herein, the terms proximal or cephalad will be used to describe a relation or orientation toward the head or heart, and the terms distal or caudal will be used to describe a position or orientation toward the feet or away from the heart. Therefore, the devices, systems, and methods can be described as having a proximal or cephalad component and a distal or caudal component. The use of these terms also applies to the implantation apparatus as used in the implantation process described, i.e., the deployment catheter handle is distal or caudal as the handle of the deployment catheter is oriented toward the feet and away from the heart.
The proximal or cephalad end 202 of a prosthesis deployment catheter 200 can be seen in
It is to be understood that the terms prosthesis and prostheses both can mean an independent component, or multiple components coupled together, or multiple components not necessarily coupled together. The prosthesis may be either coupled together at or near the targeted site, or exterior the body, or a combination of both.
In a desirable embodiment, the prosthesis is a multi-lumen prosthesis. In an alternative embodiment, the prosthesis is a straight prosthesis. The prosthesis 100 may be self-expanding, or, the prosthesis 100 can utilize an expanding member, such as a balloon or mechanical expander.
It is to be appreciated that one or more fasteners 402 can be introduced into the multi-lumen prosthesis 100 to anchor the main body 120 and/or lumen extensions 140 in place at different times or at the same time during the procedure.
II. General Methods of Endovascular Implantation
The prosthesis or prostheses 100 as just described lend themselves to implantation in a hollow organ in various ways. The prosthesis may be implanted using catheter-based technology via a peripheral intravascular access site, such as in the femoral artery, optionally with the assistance of image guidance. Image guidance includes but is not limited to fluoroscopy, ultra sound, magnetic resonance, computed tomography, or combinations thereof. Alternatively, the prosthesis can be implanted, e.g., in an open chest surgical procedure.
The implantation of the multi-lumen prosthesis 100 is first described here in a number of general steps. The multi-lumen prosthesis and each of the various tools used to implant the prosthesis are then described with additional detail below. The multi-lumen prosthesis 100 is described in section III and the various implantation apparatus are described in section IV. Additionally, the general implantation steps are then described again with additional detail below in section V.
A first implantation step can be generally described as deploying the main body 120 of the prosthesis. The deployment catheter 200 is positioned within the aortic aneurysm 20 and the main body of the pros thesis is allowed to deploy. Proximal and distal retaining means hold the main body prosthesis in a predetermined relationship to the proximal end 202 of the deployment catheter. By activating a proximal releasing means, the proximal end 108 of the main body prosthesis 120 may be partially or fully released from the deployment catheter shaft so as to allow the proximal stent 130 to expand to contact the aorta or a portion of the aorta. At this step the prosthesis may not be fully released from the deployment catheter. The main body prosthesis 120 may be attached to the deployment catheter 200 through a second proximal retaining means. The proximal end 108 or other areas of the main body prosthesis 120 is fastened to the vessel wall to resist axial migration of the prosthesis.
Next, an extension catheter 350 carrying a first prosthesis lumen extension 140 is guided through the vasculature and to the main body prosthesis 120. The first lumen extension is telescopically fitted within the second lumen 128 of the main body prosthesis 120 and allowed to radially expand. The extension catheter is then removed, leaving the lumen extension 140 coupled to the main body prosthesis 120 and extending into the contralateral iliac artery.
If the main body prosthesis 120 is attached to the deployment catheter 200 through a second proximal retaining means, a second releasing means is activated to allow the proximal end 108 of the main body prosthesis 120 to release from the deployment catheter shaft 216. The distal releasing means is then activated, allowing the distal end 110 of the main body prosthesis 120 to release from the deployment catheter shaft 216 and radially expand. The deployment catheter 200 is then removed from the body.
Lastly, the extension catheter 350 carrying a second prosthesis lumen extension 140 is guided through the vasculature and to the main body prosthesis 120. The second lumen extension 140 is telescopically fitted within the first lumen 126 of the main body prosthesis and allowed to radially expand. The extension catheter 350 is then removed, leaving the lumen extension 140 coupled to the main body prosthesis 120 and extending into the ipsilateral iliac artery. The multi-lumen prosthesis 100 is now fully deployed across the aortic aneurysm.
III. Multi-Lumen Prosthesis Assembly
The main body component 120 is sized and configured to fit within a hollow body organ and/or a blood vessel. As described in this Specification, the targeted site of deployment is within the aorta adjacent the renal arteries, as will be described in greater detail later. However, this targeted site of deployment is selected for purposes of illustrating the features of the prosthesis 100, and is not intended to be limiting.
Referring to
The septum 124 transforms at least a portion of the interior of the main body component 120 into the multi-lumen flow channel configuration. In the illustrated embodiment, the multi-lumen flow channel configuration comprises dual first and second interior lumens 126 and 128. Due to the septum 124, the dual first and second interior lumens 126 and 128 of the multi-lumen flow channel configuration do not form branched or divergent lumens. The shared common wall or seam (the septum 124) prevents divergence and maintains the lumens 126 and 128 in a non-divergent, generally parallel flow relationship (as
In the illustrated arrangement, the septum 124 runs generally along the mid-line of the main body component 120, making the multi-lumen flow channel con figuration within the main body component 120 essentially symmetric. However, it should be appreciated that the septum 124 could form a non-symmetric multi-lumen flow channel con figuration. It should also be appreciated that multiple septums can be present within the interior, transforming the interior of the main body component 120 into several flow lumens. The length of the septum can vary. In a representative embodiment, the septum 124 is typically greater than 10 mm in length and not less than 5 mm in length.
In the illustrated embodiment, the first lumen 126 defines a flow channel sized and configured to reach a targeted destination or source spaced a defined distance from the proximal opening 122, while the truncated second lumen 128 communicates with generally the same targeted destination as the proximal opening 122 of the main body component 120 itself. Furthermore, the septum 124 is sized and configured to accommodate the coupling of a flow channel extension 140 to the first lumen 126 and to the truncated second lumen 128, to likewise extend their reach to another targeted source or destination spaced from the proximal opening 122, if desired.
The second lumen 128 is truncated along at least a portion of the septum 124. As a result, the distal opening 127 of the first lumen 126 can be said to extend beyond the distal opening 129 of the second lumen 128. Still, the shared common wall (the septum 124) prevents divergence and maintains the lumens 126 and 128 in a non-divergent, generally parallel flow relationship. It is to be appreciated that the first and second lumens 126, 128 may be reversed, i.e., the second lumen 128 may extend beyond the first lumen 126 (see
In this arrangement, the multi-lumen prosthesis assembly 100 desirably includes a first and second flow channel lumen extension 140 (see
Both the first lumen 126 and the truncated second lumen 128 of the main body component 120, which is joined by the septum 124 to the first lumen 126, provide an interface region or socket that is fully enclosed within the body of the main body component 120 itself. The first lumen 126 and the truncated second lumen 128 are therefore not prone to kinking or twisting or other kinds of movement independent of the main body component 120. Passage of a guide wire through the first lumen 126 or the second lumen 128 can occur unimpeded.
Being telescopically fitted within the interface region or socket and enclosed within the main body component 120, the mechanical properties of the lumen extension 140 are supplemented by the structural support and integrity of the main body component 120 itself, and vice versa. Coupled together, the main body component 120 and the lumen extension 140 provide enhanced resistance to migration and/or separation of the lumen extension 140 from the main body component 120. Seated within the en closed interface region, the lumen extension 140 is peripherally sealed within the main body component 120 to resist leaks or see page of fluids around the lumen extension 140. The septum 124 can be tapered, curved, wavy, or otherwise non-linear to enhance the connection between the lumen extension 140 and the main body component 120.
In one illustrated use (see
The main body component 120 may include a proximal sealing stent 130 at its proximal end 108, which may extend beyond the prosthetic material 112 (see
Typically, this region of the aorta (proximal neck of the aneurysm just below the renal arteries) is also one area where one or more fasteners 402 may be introduced by a fastener device 400 to anchor the prosthesis 100 in place (see
Additional stents may be utilized throughout the main body component 120. Desirably, a minimal number of stents would be utilized within the main body component 120.
The multiple lumens 126 and 128 in the main body component 120 may typically be supported with distal stent rings 134 sewn or otherwise attached to the inside or outside of the prosthetic material 112. The proximal apices 136 of the stent rings 134 desirably are angled or curved inwardly (see
Rotational orientation of the main body component 120 within the vessel lumen or hollow body organ is accomplished with additional radiopaque markers 137 and 138 attached to the main body prosthesis 120 for visualization under fluoroscopy. Typically, these markers may be attached to the prosthetic material 112. Still, the markers 137 and 138 may be attached to the proximal sealing stent 130 or distal stent rings 134 instead of or in addition to the prosthetic material 112 to help fluoroscopically determine the location of all prosthesis openings. The radiopaque markers typically are in the form of marker bands, tight wound coils, or wire made from radiopaque materials such as platinum, platinum/iridium, tantalum, or gold for example.
Desirably, one or more markers 137, 138, are longer than the other, and are attached on opposite sides of the main body component 120 with the longer markers 137 aligned on the side with the first lumen 126 and the shorter markers 138 aligned on the side with the second lumen 128, for example. In an alternative embodiment the markers could be aligned with the septum. The markers 137 and 138 enable the clinician to determine the desired rotational orientation of the main body prosthesis 120 in the delivery system so that, upon deployment, the first distal opening 127 and the second distal opening 128 are aligned with the desired iliac arteries. The proximal markers 132 may also be included to enable the clinician to determine the position of the proximal end 108 of the main body component 120 in relation to the fixation point of the aorta. Additionally, distal markers 139 may be included to aid in the location of the distal openings 127, 129, and the insertion of the lumen extension 140. Insertion depth marker(s) 125 may be attached near the septum 124, or may be attached to the septum, or may be attached to the prosthesis material 112, for example, to indicate the location of and insertion depth for the lumen extension 140.
As previously described, the main body 120 (and the lumen extension 140) desirably utilizes a prosthetic material 112. The material 112 of the main body 120 may carry individual self-expanding, zigzag or diamond type stent rings, for example. The stent rings need not be attached to one another throughout the main body prosthesis 120. However, it may be desirable in certain locations within the prosthesis structure 120 to have attachments between the individual stent rings to provide stability and/or additional radial support.
As previously stated, the septum 124 is formed by sewing, heat bonding, stitching, or weaving opposing surfaces (i.e., the front and back) of the prosthetic material 112 of the main body component 120 together. In the region of the septum 124, the stent rings 134 extend from the septum 124 about the formed lumen, but do not enter or otherwise interrupt the septum 124 itself. The septum 124 is continuous and is formed separate from the supporting structure of stent rings 134.
The individual distal stent rings 134 allow for longitudinal main body prosthesis 120 compliance while maintaining radial support of the prosthesis lumens. This technical feature allows the prosthesis to more readily accommodate changes in vessel/aneurysm morphology.
The stents can be made, e.g., from Nitinol®. Still, other materials, manufacturing methods and designs can be used. Each of the stents may be sewn onto prosthetic material 112. In certain locations it is desired to have the stents attached to the outer diameter of the prosthetic material 112. Still, it is also contemplated that the stents could be attached to the inner diameter of the prosthetic material 112.
In the illustrated embodiment, the prosthetic material 112 is woven polyester, and the attachment of the stents is made with polyester suture. However, it is also contemplated that other attachment means could be utilized to secure the stents to the prosthetic material 112. These means include bonding; capturing the stents between two layers of prosthetic material 112; and incorporating the stents directly into the woven prosthetic material 112.
As seen in
As shown in
During use (see
As
IV. Implantation Apparatus
1. Prosthesis Deployment Catheter
As previously described, the prosthesis 100 can be sized and configured to be either straight or bifurcated form.
For the purposes of illustration,
As shown in
A. The Inner Assembly
In the illustrated embodiment (see
i. The Central Shaft
In the embodiment shown in
The central shaft 216 extends from the handle assembly 212 to the catheter tip component 222. The central shaft 216 may be made, e.g., from stainless steel or other suitable medical materials including other metals or polymers. The central shaft 216 comprises at least one lumen, desirably more than one lumen, and more desirably four lumens.
One lumen may be described as the central lumen 236 (see
ii. Catheter Tip
Desirably, the catheter tip component 222 is flexible and has a long, tapered proximal end 240 and a shorter, tapered distal end 242. The maximum diameter of the catheter tip component 222 is approximately the same as the outside diameter of the proximal end of the outer jacket 210. The proximal end 240 of the catheter tip component 222 provides a smooth tapered transition from the lumen 238 containing the guide wire 30 to the proximal edge of the outer jacket 210. This feature aids in catheter insertion and navigation through tortuous anatomy over the guide wire 30. The tapered section on the distal end 242 of the catheter tip component 222 prevents the catheter tip component 222 from inadvertently engaging the main body prosthesis 120, portions of the surrounding anatomy, or an introducer sheath or the like during removal of the deployment catheter 200 from the body.
iii. Proximal Retaining Means
a. First Proximal Retaining Means
As can be seen in
Belt loops or the like may be provided on the main body prosthesis 120 and/or lumen extensions 140 to guide and support the suture loop(s) along the path of the suture loop (see
In the illustrated embodiment, one end of the suture loop 252 is coupled to the prosthetic material 112 or one or more stents 130 at or near the proximal end 108 of the main body prosthesis 120. The suture loop 252 is then looped around the main body prosthesis 120 and the releasing means 228 in a predetermined pattern, as shown in
The suture loop 252 and releasing means 228, e.g., release wire 250, of the embodiment just described retains the prosthesis 120 in a desired relationship to the central shaft (see
As can be seen in
The first proximal retaining means 224 holds the main body prosthesis 120 in a desired configuration prior to deployment (see
The main body prosthesis 120 is retained by at least the first proximal retaining means 224 along the central shaft 216 in the cavity 234, which extends between the distal end 242 of the catheter tip component 222 and the proximal end of a spacer 206 (as best seen in
As illustrated and described, the first proximal releasing means 228 is coupled to one restrained component of the main body prosthesis 120, i.e., suture loop 252. It should be appreciated, however, that the releasing means 228 can be coupled to the main body prosthesis 120 at two or more restrained regions, so that withdrawal of the releasing means 228 frees the prosthesis at two or more restrained regions. It should also be appreciated that the releasing means 228 can comprise more than a single releasing element. For example, multiple, individual releasing wires 250 could be coupled to the main body prosthesis 120 at different regions, so that release of separate regions of the main body prosthesis 120 can be individually controlled.
b. Second Proximal Retaining
Means
Referring back to
Referring now to
The distal ends 258 of the stabilizing arms 256 are coupled to the second proximal release hub 266. In a pre-deployment configuration, the proximal ends 262 of the stabilizing arms 256 are arched back generally toward the first proximal release hub 244 (see
The proximal ends 262 of the stabilizing arms 256 include a stabilizing arm aperture 264. In the pre-deployment configuration, the stabilizing arms 256 are positioned within the proximal opening 122 of the main body prosthesis 120 and the second proximal release wire 268 is stitched or otherwise extended through the stabilizing arm aperture 264 and through the prosthesis material 112, releasably securing the stabilizing arms 256 to the main body prosthesis 120 (as best seen in
In the embodiment shown in
The second proximal retaining means 226 holds the main body prosthesis 120 in a desired con figuration prior to deployment (see
The main body prosthesis 120 is retained by the second proximal retaining means 226 in a spaced apart relationship to the central shaft 216 (see
iv. Distal Retaining Means
As can be seen in
As described for the first proximal retaining means, belt loops or the like may be provided on the main body prosthesis 120 and/or lumen extensions 140 to guide and support the suture loop(s) along the path of the suture loop. The belt loops can be spaced at desired circumferential intervals, such as every ninety degrees, for example.
In the illustrated embodiment, one end of the suture loop 274 is coupled to the prosthetic material 112 or one or more stents 134 at or near the distal end 110 of the main body prosthesis 120. The suture loop 274 is then looped around the main body prosthesis 120 and the distal releasing means 232 in a predetermined pattern, as shown in
The suture loop 274 and releasing means 232, e.g., release wire 282, of the embodiment just described retain the distal end of the main body prosthesis 120 to the central shaft 216 (see
In the embodiment shown in
The distal retaining means 220 holds the distal end 110 of the main body prosthesis 120 in a desired configuration prior to deployment of the distal end (see
In the illustrated embodiment, the distal releasing means 232 includes the distal release wire 282 that may extend through at least a portion of the central shaft 216. The proximal end of the wire 282 passes through the lumen 278 of the distal release hub 276. The proximal end of the distal release wire 282 then may extend back into the central shaft 216 through the second distal release hole or lumen 284 positioned spaced apart from the distal release hub 276. The proximal end of the release wire 282 is thereby kept in a desired relationship within or along the central shaft 216. The distal end of the distal release wire 282 is coupled to the distal control knob, such that fore and aft movement of the distal control knob moves the distal release wire 282, respectively, distally and proximally.
As illustrated and described, the distal releasing means 232 is coupled to the main body prosthesis 120 or a component of the main body prosthesis, i.e., suture loop 274. It should be appreciated, however, that the distal releasing means 232 can be coupled to the main body prosthesis 120 at two or more restrained regions, so that withdrawal of the distal releasing means 232 frees the prosthesis at two or more restrained regions. It should also be appreciated that the distal releasing means 232 can comprise more than a single releasing element. For example, multiple, individual releasing wires 282 could be coupled to the main body prosthesis 120 at different regions, so that release of separate regions of the distal end of the main body prosthesis 120 can be individually controlled.
In an alternative embodiment, the distal retaining means 220 may comprise the prosthesis material 112. As can be seen in
B. The Outer Jacket
As previously described, the outer jacket 210 serves to restrain the stents 130, 134 on the main body prosthesis 120 from expanding and allows for a controlled deployment of the main body prosthesis 120 within the body (see
As
In the illustrated embodiment, the outer jacket 210 is configured to maintain a consistent diameter throughout its entire length (see
Returning to
C. Handle Assembly
The handle assembly 212 provides the operator with longitudinal or axial control and rotational control of the deployment catheter 200 within the body and provides access to the actuator(s) or control means for deploying the main body prosthesis 120.
Referring to
In the illustrated embodiment, the central shaft 216 is captured within the handle 212 and has a guide wire receiving luer 296 and an infusion valve 297 coupled to its distal end, which is located at the distal end of the handle assembly 212 (see
To withdraw the outer jacket 210 from the catheter tip 222 and expose the proximal end of the main body prosthesis 120 (see
The jacket slide 310 is coupled to the jacket 210 and is temporarily coupled to the gear rack 308 via a spring loaded connecting pin 316. The connecting pin 316 disengages the jacket slide 310 at a predetermined position in the handle body 290 by springing or otherwise retracting into a recess 318 in the handle body 290. When the connecting pin 316 disengages, the jacket slide 310 is free to travel in both a proximal and distal direction without re-engaging the rack 308. The rack 308 desirably remains in this retracted position 314. A ratchet pawl, such as a spring backed ratchet pawl 320 may be coupled to the rack 308 to allow the rack to travel in a distal direction, but restrict proximal travel of the rack 308. Ratchet teeth 322 may be provided in the handle body 290 to engage the ratchet pawl 320.
Once the jacket slide 310 has traveled distally and the rack 308 has been disengaged, the jacket sliding knob 294 may then be used to continue the retraction of the jacket 210 from the main body prosthesis 120. The jacket slide 310 is moved distally until the outer jacket 210 is free of the main body prosthesis 120 (see
To employ the first proximal retaining means 224, the first proximal sliding knob 322 (see
The same process is repeated for the second proximal retaining means 226 and the distal retaining means 220. To employ the second proximal retaining means 226, the second proximal sliding knob 324 (see
The proximal and distal retaining means 218, 220, desirably cooperate with a release system 328 positioned within the handle housing 290 (see
As described, the main body prosthesis 120 is not released immediately from proximal end to distal end as the jacket 210 is withdrawn. The proximal and distal stent or stents 130, 134, are released in a secondary operation, which follows the withdrawal of the outer jacket 210. Placement of the prosthesis extensions 140 can therefore comprise a next step in the deployment process.
2. Lumen Extension Deployment Catheter
After the main body of the prosthesis 120 has been partially or completely deployed, a lumen extension 140, or lumen extensions, are next to be implanted. An extension deployment catheter 350 is shown in
In the illustrated embodiment, the extension catheter 350 carries the lumen extension 140 in a radially reduced configuration to the targeted site. At the targeted site, the extension catheter 350 releases the radially reduced lumen extension 140, which expands radially, and is coupled to a lumen of the main body prosthesis 120, as will be described further in section V.
As shown in
A. The Inner Assembly
In the illustrated embodiment (see
In an alternative embodiment (see
i. The Central Shaft
In the embodiments shown in
The central shaft 364 extends from the handle assembly 362 to the catheter tip component 368. The central shaft 364 may be made, e.g., from stain less steel or other suitable medical materials including other metals or polymers. The central shaft 364 comprises at least one lumen, and may comprise more than one lumen.
One lumen may be described as the central lumen 374 (see
ii. Proximal Retaining Means
The proximal retaining means 366 and the proximal releasing means 370 may function in the same or similar fashion as the retaining means 224, 226, and the releasing means 228, 230 embodied in the deployment catheter 200, as previously shown and described. As can be seen in
As described for the main body prosthesis 120, belt loops or the like may be provided on the lumen extensions 140 as well to guide and support the suture loop(s) along the path of the suture loop. The belt loops can be spaced at desired circumferential intervals, such as every ninety degrees, for example.
As can be seen in
iii. Distal Retaining Means
In an alternative embodiment, the distal retaining means 367 and the distal releasing means 371 may function in the same or similar fashion as the retaining means 220, and the releasing means 232 embodied in the deployment catheter 200, as previously shown and described. As can be seen in
As can be seen in
B. The Outer Jacket
The outer jacket 360 may function in the same or similar fashion as described for the outer jacket 210 embodied in the deployment catheter 200. The outer jacket 360 also serves to restrain the stents 146 and 150 on the lumen extension 140 from expanding and allows for a controlled deployment of the lumen extension 140 within a lumen of the main body prosthesis 120. In the illustrated arrangement, the outer jacket 360 is coupled to an actuator or knob 382 on the handle assembly 362, as will be described in greater detail below.
As
If desired, and as shown in
C. Handle Assembly
The handle assembly 362 may function in the same or similar fashion as described for the handle assembly 212 embodied in the deployment catheter 200. The handle assembly 362 provides the operator with longitudinal or axial control and rotational control of the extension deployment catheter 350 within the body and provides access to the actuator(s) or control means for deploying the lumen extension 140.
Referring to
In the illustrated embodiment, the central shaft 364 is captured within the handle 362 and has a guide wire receiving luer 388 and an infusion valve 390 coupled to its distal end, which is located at the distal end of the handle assembly 362 (see
To withdraw the outer jacket 360 from the catheter tip 368 and expose the lumen extension 140, jacket retraction means, such as the jacket retraction knob 382 may be used. The jacket retraction means 382 may include a variety of different mechanisms to selectively control the retraction of the jacket 360 from the catheter tip 368. In the illustrated embodiment, the jacket retraction means comprises two co-acting retraction knobs 382 which are available for the clinician, one positioned on each side of the handle 362.
The jacket retraction knob 382 is used to retract the jacket 360 from the lumen extension 140. The jacket retraction knob 382 is moved distally until the outer jacket 360 is free of the lumen extension 140 (see
To employ the proximal retaining means 366, the proximal release sliding knob 392 (see
The proximal retaining means 366 desirably cooperate with a release system 394 positioned within the handle housing 386. Proximal release sliding knob 392 is coupled to a release slide 396 positioned within a track 398 in or on the release system 394 (see
As described, the lumen extension 140 is not released immediately from proximal end to distal end as the jacket 360 is withdrawn. The lumen extension stent or stents 146 and 150 may be released in a secondary operation, which follows the withdrawal of the outer jacket 360. Placement of the prosthesis extensions 140 can therefore comprise a final step in the deployment process.
3. Fastener Device and Fastener
As previously described, one or more fasteners 402 (see
As can be seen in
The handle assembly 404 provides the fastening control feature for the clinician. Positioned within the handle assembly 404 is the control assembly 406. The control assembly provides motion control, such as a forward and reverse drive feature, for turning or otherwise moving the fastener 402 to or from a fastening position. The control assembly desirably includes a forward control button 412 and a reverse control button 414. The forward and reverse control buttons 412, 414 provide the clinician an ergonomic and single finger control of the fastener device 400.
The handle assembly desirably includes an indication assembly 408 to provide control information to the clinician. The indication assembly may include indication lights, i.e., LEDs, and/or the ability to produce audible signals (tones) to provide visual and/or audible indication of forward or reverse movement of the fastener 402, for example, by way of a variety of tones and/or a forward light 416 and a reverse light 418. Additionally, the indication assembly may include status tones and/or a status light 420 to provide a variety of information back to the clinician. The tones may use a variety of pitches or pulses, for example, and the status light 420 may use a variety a flash signals and illumination times, for example, to provide these different indications for the clinician, such as error indication, position indication, and timing indication, for example.
Further details of the fastener device 400 and fastener 402 can be found in U.S. patent application Ser. No. 10/307,226, filed Nov. 29, 2002, and entitled “Intraluminal Prosthesis Attachment Systems and Methods,” and in U.S. patent application Ser. No. 10/786,465, filed Feb. 29, 2004 and entitled “Systems and Methods for Attaching a Prosthesis Within a Body Lumen or Hollow Organ,” which are both incorporated herein by reference.
In this embodiment, the proximal coil 422 of the fastener 402 is formed to produce a diagonal member 424, which crosses the diameter of the helical fastener. The distal end of the fastener 402 comprises a sharpened tip 426, such as a conical tip or a chiseled tip, for example, to aid in the ease of tissue penetration. Similar helical fasteners are described in U.S. Pat. Nos. 5,964,772; 5,824,008; 5,582,616; and 6,296,656, the full disclosures of which are incorporated herein by reference.
In an alternative embodiment, the fastener device 400 and a fastener 430 may comprise features allowing the fastener 430 to be releasably secured to the fastener driver 432. As can be seen in
Located at the proximal end of the fastener delivery shaft 410 is the fastener driver 432. In the illustrated embodiment (see
The carrier 438 is sized and configured to engage a selected fastener 430. The diagonal member 436 serves to define a shape, such as a “D” shape, to engage the carrier 438, which rotates the fastener 430 positioned over the carrier 438 to achieve fastening the prosthesis to tissue. The diagonal member 436 also serves as a stop to prevent the helical fastener 430 from penetrating too far into the tissue.
As can be seen in
In an alternative embodiment, the release latch 440 may include a release spring 445, as seen in
The fastener housing 439 desirably includes a predetermined amount of internal threads 441 (e.g., two or three threads). In this configuration, the threaded portion of the housing 439 may not be continuous through out the length of the housing. The threads 441 engage the fastener 430 when the fastener is being loaded onto the fastener driver 432 (as described below) and also partially drive the helical fastener 430 out of the fastener driver 432 and into tissue. Desirably, the threaded portion of the threaded housing terminates a predetermined distance from the housing tip 443. This unthreaded portion of the threaded housing 439 provides an area in which the fastener 430 can be rotated but not be driven out of the fastener driver 432. This unthreaded feature of the housing 439 allows the fastener 430 to pull itself out of the fastener driver 432 when rotated by the driver only as long as the fastener 430 has been previously engaged with the prosthesis 120 and tissue. This feature ensures a more uniform depth of penetration for the fastener 430.
A helical fastener, such as 402 and 430, for example, may be positioned in a fastener cassette 446, as seen in
As seen in
4. Steerable Guide Device
A steerable guide device 450 may be used to establish an open path through which an operative tool, such as the fastener device 400, can be deployed for use.
In order to establish an open path for the fastener device 400, the steerable guide device 450 includes an interior guide passage 456 which extends through the interior portion of the handle 454 continuously and into and through the guide tube 452. The distal end of the handle 454 may also include a seal 457 to restrict the flow of fluids through the guide tube 452. During introduction of the guide tube through the vasculature to the targeted site, an obturator or dilator 458 having a tip component 459 (see
The handle assembly desirably includes a rotatable steering assembly 460 and a flushing port 462. The steering assembly 460 is used to deflect the proximal end 464 of the guide tube 452 to a bent or deflected configuration, as will be described later. The steering assembly 460 is rotated in a desired direction, causing the proximal end 464 to bend or deflect in a predetermined configuration. A radiopaque marker 466 can be placed on the proximal end region 464 of the guide tube 452 to allow for fluoroscopic visualization of the orientation of the deflected end region. In the bent or deflected configuration, the proximal end 464 can be oriented in a desired relationship with the targeted site.
Further details of the steerable guide device 450 can be found in U.S. patent application Ser. No. 11/254,619, filed 20 Oct. 2005, and entitled “Devices, Systems, and Methods for Guiding an Operative Tool Into an Interior Body Region,” which is incorporated herein by reference.
V. Detailed Implantation Methods
The generally described steps of implantation of the prosthesis 100 provided in Section II will now be described in greater detail. In the illustrated embodiment, deployment of the bifurcated prosthesis 100 may generally be achieved in a twelve step process, for example, and is shown generally in
Access to the vascular system is commonly provided through the use of introducers known in the art. A hemostasis introducer sheath (not shown), for example, may be first positioned in the left femoral artery, providing access for the implantation tools. A second introducer sheath (not shown) may also be positioned in the right femoral artery, providing access for the implantation tools. It is to be understood that alternative access points may also be used. Access at both the left femoral artery and the right femoral artery, for example, allows for multiple implantation tools to be positioned within the vasculature at the same time, allowing the implantation procedure to be efficiently performed.
A. Position Main Body Prosthesis
A first step includes positioning the main body pros thesis 120 at the desired location. From either the left or right femoral artery, under image guidance, the first guide wire 30 is advanced into the ipsilateral iliac artery and to the descending aorta. The deployment catheter 200 is then navigated over the first guide wire 30 to the desired location within the body, (e.g., aortic aneurysm), for deployment of the main body prosthesis 120 (as
B. Retract Outer Jacket
Next, the outer jacket 210 is retracted in a distal or caudal direction to expose the main body prosthesis 120. By first rotating the starting knob 302 on the handle assembly 212, the outer jacket 210 is initially retracted from its secure position on the catheter tip 222. After the mechanical advantage provided by the rotation of the starting knob 302 has retracted the outer jacket 210 away from the catheter tip 222, the jacket sliding knob 294 on the handle 212 may be used to further retract the jacket 210 and fully expose the main body prosthesis 120 (as
It should be appreciated that the withdrawal of the outer jacket 210 and the withdrawal of the proximal and distal releasing means 228, 230, 232, or any combination thereof, can be accomplished in a single step or process or in multiple steps. In this arrangement, a single activation mechanism can be jointly coupled to the outer jacket 210 and any or all of the releasing means 228, 230, 232, so that the outer jacket 210 and releasing means 228, 230, 232, are withdrawn in a single step, or multiple steps.
C. Release First Proximal Retaining Means
In the third general step of the deployment process, following the withdrawal of the outer jacket 210, the first proximal sliding knob 322 on the handle assembly 212 is moved distally, which causes the proximal end of the first proximal releasing means 228, i.e., the first proximal release wire 250, to be withdrawn from the first proximal retaining means 224, i.e., the suture loop 252, and allows the restrained stent or stents 130, and the proximal end 108 of the main body prosthesis 120 as a whole, to self-expand radially to the first stage deployment configuration, as seen in
D. Fasten Proximal End
The fourth general stage comprises fastening the proximal end 108 of the main body prosthesis 120 to the internal walls of the vessel or hollow body organ. From the right femoral artery, under image guidance, a second guide wire 40 is advanced using a conventional intravascular approach into the contralateral iliac artery and to the descending aorta. However, other access sites and methods can be utilized. The guide wire 40 desirably extends through the second expanded lumen 128 and through the proximal opening 122 of the main body prosthesis 120 (see
By rotating the steering assembly 460 (see
The fastener device 400 can then be actuated to apply a fastener 402 to the proximal end 108 of the main body prosthesis 120 and into the surrounding tissue (see
At this point, the fastener device 400 is withdrawn, leaving the steerable guide device 450 in place. The obturator 458 is repositioned within the interior guide passage 456, and the second guide wire 40 is navigated through the obturator lumen 470 to the desired location with respect to the main body prosthesis 120. Once the second guide wire 40 is in position, the steerable guide device 450 and the obturator 458 are both removed from the interior guide passage 456 and from the body leaving the second guide wire 40 in position within the vasculature.
E. Position First Lumen Extension
In the fifth general stage of the deployment process, following the fastening of the proximal end 108 of the main body prosthesis 120, the extension deployment catheter 350 is used to position a lumen extension 140 for deployment within a lumen of the main body prosthesis 120. From the left or right femoral artery, under image guidance, the extension catheter 350 is navigated over the second guide wire 40 to the desired location, i.e., telescopically positioned partially within the second lumen 128 of the main body prosthesis 120, as
F. Retract Extension Catheter Outer Jacket
Next, the extension catheter's outer jacket 360 must be retracted in a distal or caudal direction to expose the lumen extension 140. The jacket sliding knob 382 on the extension catheter handle 362 is urged in a distal direction to retract the jacket 360 and fully expose the lumen extension 140. The unrestrained portion or portions of the lumen extension 140 self-expand (see
G. Release Lumen Extension Proximal Retaining Means
In the seventh general step of the deployment process, following the withdrawal of the extension catheter outer jacket 360, the proximal sliding knob 382 on the extension catheter handle assembly 362 is moved distally, which causes the proximal end of the proximal releasing means 370, i.e., the proximal release wire 380, to be withdrawn from the proximal retaining means 366, i.e., the suture loop 378, and allows the restrained stent or stents 150, and the proximal end 142 of the lumen extension 140, to self-expand radially to the deployment configuration, as seen in
Prior to withdrawing the extension catheter 350, the outer jacket 360 is desirably repositioned in an abutting relationship with the catheter tip 368. The jacket sliding knob 382 on the extension catheter handle 362 is urged in a proximal direction to reposition the jacket 360 in a pre-deployment configuration. The extension catheter 350 may now be withdrawn and removed from the body. The second guide wire 40 may either be removed, or may remain until the deployment process is completed.
H. Release Second Proximal Retaining Means
In the eighth general stage of the deployment process, following the deployment of a first lumen extension 140, the second proximal retaining means 226 is released. To release the proximal end 108 of the main body prosthesis 120, the second proximal release sliding knob 324 on the handle 212 is moved distally, which causes the proximal end of the second proximal releasing means 230, i.e., the second proximal release wire 268, to be withdrawn from the prosthesis material 112 and the stabilizing arm apertures 264, and allows the stabilizing arms 256 to release from the proximal end 108 of the main body prosthesis 120, and spring proximally, as shown in
I. Release Distal Retaining Means
In the ninth general stage of the deployment process, following the release of the second proximal retaining means 226, the distal retaining means 220 is released. To release the distal end 110 of the main body prosthesis 140, the distal release sliding knob 326 on the handle 212 is moved distally, which causes the proximal end of the distal releasing means 232, i.e., the distal release wire 282, to be withdrawn from the distal retaining means 220, i.e., the distal suture loop 274, and allows the restrained stent or stents 134 to self-expand radially to the second stage deployment configuration, as seen in
Prior to withdrawing the deployment catheter 200, the outer jacket 210 is desirably repositioned in an abutting relationship with the catheter tip 222. The jacket sliding knob 294 on the catheter handle 212 is urged in a proximal direction to reposition the jacket 210 in a pre-deployment configuration. The deployment catheter 200 may now be withdrawn from the body, leaving the first guide wire 30 within the vasculature (see
J. Position Second Lumen Extension
In the tenth general stage of the deployment process, following the release of the distal retaining means 220 and withdrawal of the deployment catheter 200, the second lumen extension 140 is positioned for deployment. The general steps as describe for the deployment of the first lumen extension 140 are the same or similar, but will be repeated here for clarity. The extension deployment catheter 350 is again used to position the second lumen extension 140 for deployment within a lumen of the main body prosthesis 120. From the left or right femoral artery, for example, under image guidance, the extension catheter 350 is navigated over the first guide wire 30 to the desired location, i.e., to lescopically positioned partially within the first lumen 126 of the main body prosthesis 120, as
K. Retract Extension Catheter Outer Jacket
Next, the extension catheter's outer jacket 360 must be retracted in a distal or caudal direction to expose the lumen extension 140. The jacket sliding knob 382 on the extension catheter handle 362 is urged in a distal direction to retract the jacket 360 and fully expose the lumen extension 140. The unrestrained portion or portions of the lumen extension 140 self-expand (see
L. Release Lumen Extension Proximal Retaining Means
In the twelfth general step of the deployment process, following the withdrawal of the extension catheter outer jacket 360, the proximal sliding knob 382 on the extension catheter handle assembly 362 is moved distally, which causes the proximal end of the proximal releasing means 370, i.e., the proximal release wire 380, to be withdrawn from the proximal retaining means 366, i.e., the suture loop 378, and allows the restrained stent or stents 150, and the proximal end 142 of the lumen extension 140, to self-expand radially to the deployment configuration, as seen in
Prior to withdrawing the extension catheter 350, the outer jacket 360 is desirably repositioned in an abutting relationship with the catheter tip 368. The jacket sliding knob 382 on the extension catheter handle 362 is urged in a proximal direction to reposition the jacket 360 in a pre-deployment configuration. The extension catheter 350 may now be withdrawn and removed from the body. Both the first guide wire 30 and the second guide wire 40 may now be removed to complete the deployment process of the bifurcated prosthesis 100, as can be seen in
It is to be appreciated that the general steps just described do not necessarily need to follow the order in which they were described. For example, the second proximal retaining means may be released prior to the deployment of the first lumen extension 140, and the second guide wire may be removed prior to the completion of the deployment process. It is also to be appreciated that fasteners may be applied to the lumen extensions as well to connect the lumen extensions to the iliac arteries.
It will also be appreciated that the components and/or features of the preferred embodiments described herein may be used together or separately, while the depicted methods and devices may be combined or modified in whole or in part. It is contemplated that the components of the guiding device, fastener device, and helical fastener may be alternately oriented relative to each other, for example, offset, bi-axial, etc. Further, it will be understood that the various embodiments may be used in additional procedures not described herein, such as vascular trauma, arterial dissections, artificial heart valve attachment and attachment of other prosthetic device within the vascular system and generally within the body.
The foregoing is considered as illustrative only of the principles of the invention. Furthermore, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the invention to the exact construction and operation shown and described. While the preferred embodiment has been described, the details may be changed without departing from the invention, which is defined by the claims.
The desired embodiments of the invention are described above in detail for the purpose of setting forth a complete disclosure and for the sake of explanation and clarity. Those skilled in the art will envision other modifications within the scope and spirit of the present disclosure.
This application is divisional of co-pending U.S. patent application Ser. No. 11/254,950, filed 20 Oct. 2005, which is a continuation-in-part of co-pending U.S. patent application Ser. No. 11/254,619, filed 20 Oct. 2005, and entitled “Devices, Systems, and Methods for Guiding an Operative Tool Into an Interior Body Region”, which is incorporated herein by reference. U.S. patent application Ser. No. 11/254,950 also is a continuation-in-part of U.S. patent application Ser. No. 10/692,283, filed 23 Oct. 2003, now U.S. Pat. No. 7,147,657, and entitled “Prosthesis Delivery Systems and Methods,” which claims the benefit of U.S. Provisional Patent Application Ser. No. 60/488,753, filed 21 Jul. 2003, and entitled “Endoprosthesis Delivery Systems and Methods.” U.S. patent application Ser. No. 11/254,950 also is a continuation-in-part of co-pending U.S. patent application Ser. No. 10/786,465, filed 25 Feb. 2004, and entitled “Systems and Methods for Attaching a Prosthesis Within a Body Lumen or Hollow Organ,” which is a continuation-in-part of U.S. patent application Ser. No. 10/693,255, now U.S. Pat. No. 6,929,661, and entitled “Multi-Lumen Prosthesis Systems and Methods,” which claims the benefit of U.S. Provisional Patent Application Ser. No. 60/489,011, filed Jul. 21, 2003, and entitled “Bifurcated Prosthesis Systems and Methods.” U.S. patent application Ser. No. 11/254,950 also is a continuation-in-part of co-pending U.S. patent application Ser. No. 10/307,226, filed 29 Nov. 2002, and entitled “Intraluminal Prosthesis Attachment Systems and Methods.” U.S. patent application Ser. No. 11/254,950 is also a continuation-in-part of U.S. patent application Ser. No. 10/669,881, filed 24 Sep. 2003, now U.S. Pat. No. 7,491,232, entitled “Catheter-Based Fastener Implantation Apparatus and Methods with Implantation Force Resolutions.” U.S. patent application Ser. No. 11/254,950 is also a continuation-in-part of U.S. patent application Ser. No. 11/166,411, filed 24 Jun. 2005, entitled “Endovascular Aneurysm Repair System,” which is a division of U.S. patent application Ser. No. 10/271,334, filed 15 Oct. 2002, now U.S. Pat. No. 6,960,217, which claims the benefit of U.S. Provisional Patent Application Ser. No. 60/333,937, filed 28 Nov. 2001, and entitled “Endovascular Aneurysm Repair System.”
Number | Name | Date | Kind |
---|---|---|---|
2033039 | Limpert | Mar 1936 | A |
3499222 | Linkow et al. | Mar 1970 | A |
3686740 | Shiley | Aug 1972 | A |
3799172 | Szpur | Mar 1974 | A |
4140126 | Choudhury | Feb 1979 | A |
4255820 | Rothermel et al. | Mar 1981 | A |
4307722 | Evans | Dec 1981 | A |
4580568 | Gianturco | Apr 1986 | A |
4625597 | Cast | Dec 1986 | A |
4694827 | Weiner et al. | Sep 1987 | A |
4781682 | Patel | Nov 1988 | A |
4898577 | Badger et al. | Feb 1990 | A |
4899747 | Garren et al. | Feb 1990 | A |
4921484 | Hillstead | May 1990 | A |
4990151 | Wallsten | Feb 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
5030204 | Badger et al. | Jul 1991 | A |
5042707 | Taheri | Aug 1991 | A |
5044519 | Aoyama | Sep 1991 | A |
5071407 | Termin et al. | Dec 1991 | A |
5104399 | Lazarus | Apr 1992 | A |
5185004 | Lashinski et al. | Feb 1993 | A |
5192314 | Daskalakis | Mar 1993 | A |
5207695 | Trout, III | May 1993 | A |
5282824 | Gianturco | Feb 1994 | A |
5290295 | Querals et al. | Mar 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5320630 | Ahmed | Jun 1994 | A |
5330490 | Wilk et al. | Jul 1994 | A |
5330503 | Yoon | Jul 1994 | A |
5334196 | Scott et al. | Aug 1994 | A |
5364351 | Heinzelman et al. | Nov 1994 | A |
5383880 | Hooven | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5409498 | Braddock et al. | Apr 1995 | A |
5456713 | Chutter | Oct 1995 | A |
5456714 | Owen | Oct 1995 | A |
5470337 | Moss | Nov 1995 | A |
5474568 | Scott | Dec 1995 | A |
5480382 | Hammerslag et al. | Jan 1996 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5489295 | Piplani et al. | Feb 1996 | A |
5522881 | Lentz | Jun 1996 | A |
5531686 | Lundquist et al. | Jul 1996 | A |
5534007 | St. Germain et al. | Jul 1996 | A |
5562728 | Lazarus et al. | Oct 1996 | A |
5571171 | Barone et al. | Nov 1996 | A |
5571173 | Parodi | Nov 1996 | A |
5582616 | Bolduc et al. | Dec 1996 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5626613 | Schmieding | May 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5662675 | Polanskyj Stockert et al. | Sep 1997 | A |
5662683 | Kay | Sep 1997 | A |
5662700 | Lazarus | Sep 1997 | A |
5676696 | Marcade | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5683450 | Goicoechea et al. | Nov 1997 | A |
5693084 | Chuter | Dec 1997 | A |
5693086 | Goicoechea et al. | Dec 1997 | A |
5700269 | Pinchuk et al. | Dec 1997 | A |
5702343 | Alferness | Dec 1997 | A |
5702365 | King | Dec 1997 | A |
5702408 | Wales et al. | Dec 1997 | A |
5707376 | Kavteledze et al. | Jan 1998 | A |
5713907 | Bogendijk et al. | Feb 1998 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5749921 | Lenker et al. | May 1998 | A |
5755777 | Chuter | May 1998 | A |
5762458 | Wang et al. | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5776142 | Gunderson | Jul 1998 | A |
5800528 | Lederman et al. | Sep 1998 | A |
5810882 | Bolduc et al. | Sep 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5824008 | Bolduc et al. | Oct 1998 | A |
5824037 | Fogarty et al. | Oct 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5830221 | Stein et al. | Nov 1998 | A |
5830229 | Konya et al. | Nov 1998 | A |
5843160 | Rhodes | Dec 1998 | A |
5855565 | Bar-Cohen et al. | Jan 1999 | A |
5855598 | Pinchuk | Jan 1999 | A |
5861003 | Latson et al. | Jan 1999 | A |
5865791 | Whayne | Feb 1999 | A |
5876432 | Lau et al. | Mar 1999 | A |
5904713 | Leschinsky | May 1999 | A |
5906619 | Olson et al. | May 1999 | A |
5906641 | Thomson et al. | May 1999 | A |
5916263 | Goicoechea et al. | Jun 1999 | A |
5944750 | Tanner et al. | Aug 1999 | A |
5957940 | Tanner et al. | Sep 1999 | A |
5964772 | Bolduc et al. | Oct 1999 | A |
5968053 | Revelas | Oct 1999 | A |
5972023 | Tanner et al. | Oct 1999 | A |
5980548 | Evans et al. | Nov 1999 | A |
5993401 | Inbe et al. | Nov 1999 | A |
5993466 | Yoon | Nov 1999 | A |
5997556 | Tanner | Dec 1999 | A |
6016810 | Ravenscroft | Jan 2000 | A |
6024703 | Zanelli et al. | Feb 2000 | A |
6024763 | Lenker et al. | Feb 2000 | A |
6027462 | Greene et al. | Feb 2000 | A |
6070589 | Keith et al. | Jun 2000 | A |
6074418 | Buchanan et al. | Jun 2000 | A |
6077214 | Mortier et al. | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6086582 | Altman et al. | Jul 2000 | A |
6090137 | Schmitt | Jul 2000 | A |
6123722 | Fogarty et al. | Sep 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6129685 | Howard, III | Oct 2000 | A |
6145509 | Tanner | Nov 2000 | A |
6146339 | Biagtan et al. | Nov 2000 | A |
6152144 | Lesh et al. | Nov 2000 | A |
6168610 | Marin et al. | Jan 2001 | B1 |
6179809 | Khairkhahan et al. | Jan 2001 | B1 |
6197049 | Shaolian et al. | Mar 2001 | B1 |
6203550 | Olson | Mar 2001 | B1 |
6203568 | Lombardi et al. | Mar 2001 | B1 |
6217597 | Tanner | Apr 2001 | B1 |
6224540 | Lederman et al. | May 2001 | B1 |
6248118 | Tanner et al. | Jun 2001 | B1 |
6258119 | Hussein et al. | Jul 2001 | B1 |
6270516 | Tanner et al. | Aug 2001 | B1 |
6273858 | Fox et al. | Aug 2001 | B1 |
6286514 | Lemelson | Sep 2001 | B1 |
6287315 | Wijeratne et al. | Sep 2001 | B1 |
6293906 | Vanden Hoek et al. | Sep 2001 | B1 |
6296656 | Bolduc et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6309403 | Minor et al. | Oct 2001 | B1 |
6319278 | Quinn | Nov 2001 | B1 |
6336933 | Parodi | Jan 2002 | B1 |
6346118 | Baker et al. | Feb 2002 | B1 |
6352561 | Leopold et al. | Mar 2002 | B1 |
6361556 | Chuter | Mar 2002 | B1 |
6368345 | Dehdashtian et al. | Apr 2002 | B1 |
6371919 | Tanner et al. | Apr 2002 | B1 |
6398803 | Layne et al. | Jun 2002 | B1 |
6402680 | Mortier et al. | Jun 2002 | B2 |
6402780 | Williamson, IV et al. | Jun 2002 | B2 |
6409757 | Trout, III et al. | Jun 2002 | B1 |
6423059 | Hanson et al. | Jul 2002 | B1 |
6425856 | Shapland et al. | Jul 2002 | B1 |
6428565 | Wisselink | Aug 2002 | B1 |
6454796 | Barkman et al. | Sep 2002 | B1 |
6458152 | Khosravi et al. | Oct 2002 | B1 |
6468260 | Bumbalough et al. | Oct 2002 | B1 |
6482224 | Michler et al. | Nov 2002 | B1 |
6520974 | Tanner et al. | Feb 2003 | B2 |
6544253 | Tanner | Apr 2003 | B1 |
6558425 | Rockwood, Jr. | May 2003 | B2 |
6562051 | Bolduc et al. | May 2003 | B1 |
6565597 | Fearnot et al. | May 2003 | B1 |
6576009 | Ryan et al. | Jun 2003 | B2 |
6580417 | Rosenberg et al. | Jun 2003 | B2 |
6592593 | Parodi et al. | Jul 2003 | B1 |
6592615 | Marcade et al. | Jul 2003 | B1 |
6595912 | Lau et al. | Jul 2003 | B2 |
6607555 | Patterson et al. | Aug 2003 | B2 |
6616684 | Vidlund et al. | Sep 2003 | B1 |
6652555 | Vantassel et al. | Nov 2003 | B1 |
6652572 | Kugler et al. | Nov 2003 | B2 |
6663558 | Lau et al. | Dec 2003 | B2 |
6675809 | Stack et al. | Jan 2004 | B2 |
6685620 | Gifford, III et al. | Feb 2004 | B2 |
6702763 | Murphy et al. | Mar 2004 | B2 |
6702844 | Lazarus | Mar 2004 | B1 |
6719174 | Swift | Apr 2004 | B1 |
6730119 | Smalling | May 2004 | B1 |
6746460 | Gannoe et al. | Jun 2004 | B2 |
6800081 | Parodi | Oct 2004 | B2 |
6878164 | Kujawski et al. | Apr 2005 | B2 |
6929661 | Bolduc et al. | Aug 2005 | B2 |
6960217 | Bolduc | Nov 2005 | B2 |
6984241 | Lubbers et al. | Jan 2006 | B2 |
6986784 | Weiser et al. | Jan 2006 | B1 |
7033384 | Gannoe et al. | Apr 2006 | B2 |
7037343 | Imran | May 2006 | B2 |
7060023 | French et al. | Jun 2006 | B2 |
7081086 | Lau et al. | Jul 2006 | B2 |
7081129 | Chobotov | Jul 2006 | B2 |
7128754 | Bolduc | Oct 2006 | B2 |
7155295 | Lau et al. | Dec 2006 | B2 |
7179225 | Shluzas et al. | Feb 2007 | B2 |
7306623 | Watson | Dec 2007 | B2 |
7361137 | Taylor et al. | Apr 2008 | B2 |
7422558 | Lau et al. | Sep 2008 | B2 |
7491232 | Bolduc et al. | Feb 2009 | B2 |
7544198 | Parodi | Jun 2009 | B2 |
7591842 | Parodi | Sep 2009 | B2 |
7637932 | Bolduc et al. | Dec 2009 | B2 |
7727189 | Vantassel et al. | Jun 2010 | B2 |
7823267 | Bolduc | Nov 2010 | B2 |
7828838 | Bolduc et al. | Nov 2010 | B2 |
7959663 | Bolduc | Jun 2011 | B2 |
8075570 | Bolduc et al. | Dec 2011 | B2 |
8083752 | Bolduc | Dec 2011 | B2 |
8092519 | Bolduc | Jan 2012 | B2 |
20020026144 | Patterson | Feb 2002 | A1 |
20020029077 | Leopold et al. | Mar 2002 | A1 |
20020058855 | Cyril, Jr. et al. | May 2002 | A1 |
20020065485 | DuBois et al. | May 2002 | A1 |
20020099432 | Yee | Jul 2002 | A1 |
20020133054 | Murphy et al. | Sep 2002 | A1 |
20020156365 | Tsekos | Oct 2002 | A1 |
20030018358 | Saadat | Jan 2003 | A1 |
20030100943 | Bolduc | May 2003 | A1 |
20030149463 | Solymar et al. | Aug 2003 | A1 |
20030158570 | Ferrazzi | Aug 2003 | A1 |
20030163085 | Tanner et al. | Aug 2003 | A1 |
20030204249 | Letort | Oct 2003 | A1 |
20030233140 | Hartley et al. | Dec 2003 | A1 |
20040002731 | Aganon et al. | Jan 2004 | A1 |
20040039405 | Petrovic et al. | Feb 2004 | A1 |
20040054352 | Adams et al. | Mar 2004 | A1 |
20040093057 | Bolduc et al. | May 2004 | A1 |
20040127916 | Bolduc et al. | Jul 2004 | A1 |
20040138734 | Chobotov et al. | Jul 2004 | A1 |
20040206363 | Mccarthy et al. | Oct 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040243170 | Suresh et al. | Dec 2004 | A1 |
20040260322 | Rudko et al. | Dec 2004 | A1 |
20040260383 | Stelter et al. | Dec 2004 | A1 |
20050038506 | Webler et al. | Feb 2005 | A1 |
20050043790 | Seguin | Feb 2005 | A1 |
20050070992 | Bolduc et al. | Mar 2005 | A1 |
20050113906 | Bolduc et al. | May 2005 | A9 |
20050187613 | Bolduc | Aug 2005 | A1 |
20050197716 | Sharkey et al. | Sep 2005 | A1 |
20050240258 | Bolduc et al. | Oct 2005 | A1 |
20050240260 | Bolduc | Oct 2005 | A1 |
20060100640 | Bolduc et al. | May 2006 | A1 |
20060259125 | Peacock, III | Nov 2006 | A1 |
20070021753 | Bolduc et al. | Jan 2007 | A1 |
20070021829 | Bolduc et al. | Jan 2007 | A1 |
20070032860 | Brooks et al. | Feb 2007 | A1 |
20070073389 | Bolduc et al. | Mar 2007 | A1 |
20080065117 | Bolduc et al. | Mar 2008 | A1 |
20080065189 | Bolduc | Mar 2008 | A1 |
20080065191 | Bolduc et al. | Mar 2008 | A1 |
20080097489 | Goldfarb et al. | Apr 2008 | A1 |
20080132996 | Drasler et al. | Jun 2008 | A1 |
20090082852 | Bolduc et al. | Mar 2009 | A1 |
20090099650 | Bolduc et al. | Apr 2009 | A1 |
20090112303 | Bolduc | Apr 2009 | A1 |
20100094400 | Bolduc et al. | Apr 2010 | A1 |
20120065661 | Bolduc | Mar 2012 | A1 |
Number | Date | Country |
---|---|---|
2002353807 | Jun 2003 | AU |
2004277897 | Apr 2005 | AU |
2008243229 | Dec 2008 | AU |
2004287355 | Jun 2011 | AU |
2006305688 | Dec 2012 | AU |
2265131 | Sep 1999 | CA |
2344252 | Mar 2000 | CA |
2729464 | Jun 2003 | CA |
2626505 | Apr 2007 | CA |
2626106 | May 2007 | CA |
2625082 | Jul 2008 | CA |
2740831 | Apr 2010 | CA |
2464048 | Jun 2010 | CA |
2464900 | Apr 2011 | CA |
2546721 | Sep 2013 | CA |
1019461 | Dec 1992 | CN |
1422139 | Jun 2003 | CN |
1596087 | Mar 2005 | CN |
1596088 | Mar 2005 | CN |
1856280 | Nov 2006 | CN |
1870949 | Nov 2006 | CN |
1870951 | Nov 2006 | CN |
1997318 | Jul 2007 | CN |
101151002 | Mar 2008 | CN |
101267788 | Sep 2008 | CN |
101330882 | Dec 2008 | CN |
101352375 | Jan 2009 | CN |
101360466 | Feb 2009 | CN |
101460104 | Jun 2009 | CN |
101466316 | Jun 2009 | CN |
100525719 | Aug 2009 | CN |
101330882 | Apr 2011 | CN |
101466316 | Jun 2012 | CN |
33 33 427 | May 1991 | DE |
69228184 | Sep 1999 | DE |
10034105 | Apr 2002 | DE |
10297483 | Dec 2004 | DE |
0 321 912 | Jun 1989 | EP |
0 663 184 | Jul 1995 | EP |
0 835 642 | Aug 2002 | EP |
1 369 098 | Dec 2003 | EP |
1 440 673 | Jul 2004 | EP |
1675528 | Jul 2006 | EP |
1725172 | Nov 2006 | EP |
1734872 | Dec 2006 | EP |
1948080 | Jul 2008 | EP |
2119416 | Nov 2009 | EP |
2349086 | Aug 2011 | EP |
2349087 | Aug 2011 | EP |
2299548 | Aug 1976 | FR |
2396824 | Jul 2004 | GB |
2417208 | Feb 2006 | GB |
1073240 | Aug 2009 | HK |
2001509398 | Jul 2001 | JP |
2001522292 | Nov 2001 | JP |
2002526193 | Aug 2002 | JP |
2005046648 | Feb 2005 | JP |
2005510293 | Apr 2005 | JP |
2005510303 | Apr 2005 | JP |
2007508894 | Apr 2007 | JP |
2007508895 | Apr 2007 | JP |
2007523694 | Aug 2007 | JP |
2007535339 | Dec 2007 | JP |
2009512497 | Mar 2009 | JP |
2009512498 | Mar 2009 | JP |
2009512499 | Mar 2009 | JP |
2009078172 | Apr 2009 | JP |
2009095684 | May 2009 | JP |
2009106763 | May 2009 | JP |
2009106768 | May 2009 | JP |
2009106775 | May 2009 | JP |
2009112827 | May 2009 | JP |
2009519046 | May 2009 | JP |
4405262 | Jan 2010 | JP |
10506026 | Feb 2010 | JP |
2010051786 | Mar 2010 | JP |
4465359 | May 2010 | JP |
2011062570 | Mar 2011 | JP |
4699445 | Jun 2011 | JP |
WO-9300868 | Jan 1993 | WO |
WO-9521592 | Aug 1995 | WO |
WO-9603925 | Feb 1996 | WO |
WO-9703616 | Feb 1997 | WO |
WO-9703616 | Feb 1997 | WO |
WO-9712562 | Apr 1997 | WO |
WO-9717039 | May 1997 | WO |
WO-9717913 | May 1997 | WO |
WO-9853761 | Dec 1998 | WO |
WO-9930637 | Jun 1999 | WO |
WO-9933402 | Jul 1999 | WO |
WO-9933402 | Sep 1999 | WO |
WO-9953845 | Oct 1999 | WO |
WO-9953845 | Oct 1999 | WO |
WO-0016701 | Mar 2000 | WO |
WO-0035350 | Jun 2000 | WO |
WO-0064357 | Nov 2000 | WO |
WO-0160432 | Aug 2001 | WO |
WO-03032870 | Apr 2003 | WO |
WO-03045283 | Jun 2003 | WO |
WO-03045467 | Jun 2003 | WO |
WO-03045467 | Jun 2003 | WO |
WO-03079935 | Oct 2003 | WO |
WO-2005032333 | Apr 2005 | WO |
WO-2005032333 | Apr 2005 | WO |
WO-2005037076 | Apr 2005 | WO |
WO-2005044073 | May 2005 | WO |
WO-2005044073 | May 2005 | WO |
WO-2005044148 | May 2005 | WO |
WO-2005067660 | Jul 2005 | WO |
WO-2005081936 | Sep 2005 | WO |
WO-2005081936 | Sep 2005 | WO |
WO-2005102181 | Nov 2005 | WO |
WO-2007046953 | Apr 2007 | WO |
WO-2007046953 | Apr 2007 | WO |
WO-2007046954 | Apr 2007 | WO |
WO-2007046954 | Apr 2007 | WO |
WO-2007046955 | Apr 2007 | WO |
WO-2007046955 | Apr 2007 | WO |
WO-2007047023 | Apr 2007 | WO |
WO-2007047023 | Apr 2007 | WO |
WO-2005067660 | Apr 2007 | WO |
WO-2007053233 | May 2007 | WO |
WO-2007053233 | Jan 2008 | WO |
WO-2010044851 | Apr 2010 | WO |
WO-2010044856 | Apr 2010 | WO |
WO-2010044854 | Apr 2010 | WO |
WO-2010044855 | Apr 2010 | WO |
Entry |
---|
Gadacz, T. et al. (Nov. 1995). “The Spiral Tacker: A New Technique for Stabilizing Prosthetic Mesh in Laparoscopic Hernia Repair,” Surgical Rounds pp. 461-467. |
Hatchett, R.L. et al. (1995). “Extraperitoneal Endoscopic Burch Repair Using a Tacker Mesh Technique,” Circa pp. 1-4. |
Medical Technologies. (Oct. 1995). “Laparoscopic Surgery,” Medical Data International, Inc. MedPro, p. 190. |
Newman, L. et al. (1995). “Tacker-Assisted TAPP Procedure,” Circa, 2 pages. |
Non Final Office Action mailed on May 18, 2004, for U.S. Appl. No. 10/271,334, filed Oct. 15, 2002, 8 pages. |
Examiner's Interview Summary mailed Feb. 11, 2005, for U.S. Appl. No. 10/271,334, filed Oct. 15, 2002, 1 page. |
Notice of Allowability mailed on Feb. 11, 2005, for U.S. Appl. No. 10/271,334, filed Oct. 15, 2002, 4 pages. |
Notice of Allowance mailed on Mar. 17, 2005, for U.S. Appl. No. 10/271,334, filed Oct. 15, 2002, 3 pages. |
Notice of Allowance mailed on Aug. 26, 2005, for U.S. Appl. No. 10/271,334, filed Oct. 15, 2002, 3 pages. |
Non Final Office Action mailed on May 30, 2012, for U.S. Appl. No. 12/653,219, filed Dec. 10, 2009, 16 pages. |
Non Final Office Action mailed on May 5, 2009, for U.S. Appl. No. 11/166,411, filed Jun. 24, 2005, 7 pages. |
Final Office Action mailed on Dec. 3, 2009, for U.S. Appl. No. 11/166,411, filed Jun. 24, 2005, 5 pages. |
Notice of Allowance mailed on Jan. 6, 2011, for U.S. Appl. No. 11/166,411, filed Jun. 24, 2005, 4 pages. |
Notice of Allowance mailed on Aug. 23, 2011, for U.S. Appl. No. 11/166,411, filed Jun. 24, 2005, 5 pages. |
Non-Final Office Action mailed on Oct. 6, 2008, for U.S. Appl. No. 11/540,427, filed Sep. 29, 2006, 9 pages. |
Final Office Action mailed on Jul. 21, 2009, for U.S. Appl. No. 11/540,427, filed Sep. 29, 2006, 8 pages. |
Notice of Allowance mailed on Apr. 29, 2011, for U.S. Appl. No. 11/540,427, filed Sep. 29, 2006, 8 pages. |
Non-Final Office Action mailed on Nov. 12, 2010, for U.S. Appl. No. 11/540,428, filed Sep. 29, 2006, 7 pages. |
Final Office Action mailed on Aug. 4, 2011, for U.S. Appl. No. 11/540,428, filed Sep. 29, 2006, 9 pages. |
Non-Final Office Action mailed on May 20, 2010, for U.S. Appl. 11/978,752, filed Oct. 30, 2007, 5 pages. |
Final Office Action mailed Dec. 22, 2010, for U.S. Appl. 11/978,752, filed Oct. 30, 2007, 6 pages. |
Notice of Allowance mailed on Aug. 31, 2011, for U.S. Appl. No. 11/978,752, filed Oct. 30, 2007, 5 pages. |
Non-Final Office Action mailed on Sep. 3, 2010, for U.S. Appl. No. 11/978,753, filed Oct. 30, 2007, 7 pages. |
Final Office Action mailed on May 2, 2011, for U.S. Appl. No. 11/978,753, filed Oct. 30, 2007, 8 pages. |
Non-Final Office Action mailed on Oct. 6, 2011, for U.S. Appl. No. 12/315,015, filed Nov. 26, 2008, 10 pages. |
Non-Final Office Action mailed on Mar. 13, 2006, for U.S. Appl. No. 10/307,226, filed Nov. 29, 2002, 6 pages. |
Final Office Action mailed on Dec. 12, 2006, for U.S. Appl. No. 10/307,226, filed Nov. 29, 2002, 5 pages. |
Non-Final Office Action mailed on Jun. 12, 2007, for U.S. Appl. No. 10/307,226, filed Nov. 29, 2002, 5 pages. |
Final Office Action mailed on Jun. 27, 2008, for U.S. Appl. No. 10/307,226, filed Nov. 29, 2002, 5 pages. |
Non-Final Office Action mailed on Sep. 9, 2009, for U.S. Appl. No. 10/307,226, filed Nov. 29, 2002, 6 pages. |
Non-Final Office Action mailed on Jan. 27, 2006, for U.S. Appl. No. 10/669,881, filed Sep. 24, 2003, 5 pages. |
Final Office Action mailed Jan. 25, 2008, for U.S. Appl. No. 10/669,881, filed Sep. 24, 2003, 7 pages. |
Notice of Allowance mailed Oct. 8, 2008, for U.S. Appl. No. 10/669,881, filed Sep. 24, 2003, 6 pages. |
Notice of Allowance mailed on Mar. 9, 2010, for U.S. Appl. No. 11/254,444, filed Oct. 20, 2005, 6 pages. |
Notice of Allowance mailed on Jun. 29, 2010, for U.S. Appl. No. 11/254,444, filed Oct. 20, 2005, 6 pages. |
Non-Final Office Action mailed on Oct. 1, 2009, for U.S. Appl. No. 11/254,619, filed Oct. 20, 2005, 5 pages. |
Final Office Action mailed on Jun. 30, 2010, for U.S. Appl. No. 11/254,619, filed Oct. 20, 2005, 10 pages. |
Non-Final Office Action mailed on Feb. 3, 2011, for U.S. Appl. No. 11/254,619, filed Oct. 20, 2005, 8 pages. |
Final Office Action mailed on Oct. 20, 2011, for U.S. Appl. No. 11/254,619, filed Oct. 20, 2005, 11pages. |
Non-Final Office Action mailed on Mar. 30, 2009, for U.S. Appl. No. 11/254,950, filed Oct. 20, 2005, 5 pages. |
Notice of Allowance mailed on Feb. 26, 2010, for U.S. Appl. No. 11/254,950, filed Oct. 20, 2005, 4 pages. |
Notice of Allowance mailed on Jun. 22, 2010, for U.S. Appl. No. 11/254,950, filed Oct. 20, 2005, 4 pages. |
Non-Final Office Action mailed on May 14, 2008, for U.S. Appl. No. 11/255,116, filed Oct. 20, 2005, 14 pages. |
Notice of Allowance mailed on Aug. 10, 2009, for U.S. Appl. No. 11/255,116, filed Oct. 20, 2005, 4 pages. |
Non-Final Office Action mailed on Jul. 23, 2007, for U.S. Appl. No. 10/786,465, filed Feb. 25, 2004, 6 pages. |
Final Office Action mailed on Jan. 21, 2009, for U.S. Appl. No. 10/786,465, filed Feb. 25, 2004, 7 pages. |
Non-Final Office Action mailed on Mar. 26, 2010, for U.S. Appl. No. 10/786,465, filed Feb. 25, 2004, 7 pages. |
Notice of Allowance mailed on Mar. 14, 2012, for U.S. Appl. No. 10/786,465, filed Feb. 25, 2004, 6 pages. |
Non-Final Office Action mailed Sep. 1, 2010, for U.S. Appl. No. 11/488,305, filed Jul. 18, 2006, 7 pages. |
Final Office Action mailed on Apr. 13, 2011, for U.S. Appl. No. 11/488,305, filed Jul. 18, 2006, 8 pages. |
Non-Final Office Action mailed on Oct. 31, 2011, for U.S. Appl. No. 11/488,305, filed Jul. 18, 2006, 6 pages. |
International Search Report mailed on Mar. 6, 2003, for PCT Patent Application No. PCT/US02/32753, filed on Oct. 15, 2002, one page. |
Written Opinion mailed on Aug. 26, 2003, for PCT Patent Application No. PCT/US02/32753, filed on Oct. 15, 2002, 4 pages. |
International Preliminary Report on Patentability mailed on Sep. 1, 2004, for PCT Patent Application No. PCT/US02/32753, filed on Oct. 15, 2002, 3 pages. |
International Search Report mailed on May 8, 2003, for PCT Patent Application No. PCT/US02/38365, filed on Nov. 29, 2002, 4 pages. |
Written Opinion mailed on Oct. 27, 2003, for PCT Patent Application No. PCT/US02/38365, filed on Nov. 29, 2002, 4 pages. |
International Preliminary Report on Patentability mailed on Mar. 1, 2004, for PCT Patent Application No. PCT/US02/38365, filed on Nov. 29, 2002, 3 pages. |
International Search Report mailed on Feb. 24, 2006, for PCT Patent Application No. PCT/US2004/029402, filed on Sep. 10, 2004, 3 pages. |
Written Opinion mailed on Feb. 24, 2006, for PCT Patent Application No. PCT/US2004/029402, filed on Sep. 10, 2004, 3 pages. |
International Preliminary Report on Patentability mailed on Jul. 10, 2006, for PCT Patent Application No. PCT/US2004/029402, filed on Sep. 10, 2004, 3 pages. |
International Search Report mailed on Mar. 30, 2007, for PCT Patent Application No. PCT/US2006/033741, filed on Aug. 29, 2006, 2 pages. |
Written Opinion mailed on Mar. 30, 2007, for PCT Patent Application No. PCT/US2006/033741, filed on Aug. 29, 2006, 4 pages. |
International Preliminary Examination Report mailed on Jul. 28, 2007, for PCT Patent Application No. PCT/US2006/033741, filed on Aug. 29, 2006, 5 pages. |
International Search Report mailed on Aug. 15, 2007, for PCT Patent Application No. PCT/US06/033749, filed on Aug. 29, 2006, 3 pages. |
Written Opinion mailed on Aug. 15, 2007, for PCT Patent Application No. PCT/US06/033749, filed on Aug. 29, 2006, 5 pages. |
International Preliminary Report on Patentability mailed on Jun. 18, 2008, for PCT Patent Application No. PCT/US06/033749, filed on Aug. 29, 2006, 6 pages. |
International Search Report mailed on Jul. 8, 2008, for PCT Patent Application No. PCT/US2006/033747, filed on Aug. 29, 2006, 2 pages. |
Written Opinion mailed on Jul. 8, 2008, for PCT Patent Application No. PCT/US2006/033747, filed on Aug. 29, 2006, 3 pages. |
International Search Report mailed on Sep. 25, 2007, PCT Patent Application No. PCT/US05/005627, filed Feb. 22, 2005, 3 pages. |
Written Opinion mailed on Sep. 25, 2007, PCT Patent Application No. PCT/US05/005627, filed Feb. 22, 2005, 3 pages. |
International Preliminary Examination Report mailed on Apr. 7, 2009, PCT Patent Application No. PCT/US05/005627, filed Feb. 22, 2005, 5 pages. |
International Search Report mailed on Aug. 30, 2007, for PCT/US2006/037085, filed on Sep. 22, 2006, one page. |
Written Opinion mailed on Aug. 30, 2007, for PCT/US2006/037085, filed on Sep. 22, 2006, 7 pages. |
International Preliminary Report on Patentability mailed on Jul. 24, 2008, for PCT/US2006/037085, filed on Sep. 22, 2006, 9 pages. |
International Search Report mailed on Dec. 11, 2009, for PCT/US2009/005604, filed on Oct. 14, 2009, 3 pages. |
Written Opinion mailed on Dec. 11, 2009, for PCT/US2009/005604, filed on Oct. 14, 2009, 7 pages. |
International Search Report mailed on Dec. 18, 2009, for PCT/US2009/005609, filed Oct. 14, 2009, 3 pages. |
Written Opinion mailed on Dec. 18, 2009, for PCT/US2009/005609, filed Oct. 14, 2009, 6 pages. |
Anonymous. (1995). “5mm Origin Tacker™ It Runs in Circles Around Staples,” Guidant Origin Advertising Literature, 2 pages. |
“U.S. Appl. No. 10/271,334, Examiner Interview Summary mailed Feb. 11, 2005”, 2 pgs. |
“U.S. Appl. No. 10/271,334, Response filed Nov. 22, 2004 to Non Final Office Action mailed May 18, 2004”, 6 pgs. |
“U.S. Appl. No. 10/692,282, Non Final Office Action mailed Aug. 30, 2005”, 6 pgs. |
“U.S. Appl. No. 10/692,282, Notice of Allowance mailed Jun. 13, 2006”, 6 pgs. |
“U.S. Appl. No. 10/692,282, Response filed Feb. 28, 2006 to Non Final Office Action mailed Aug. 30, 2005”, 5 pgs. |
“U.S. Appl. No. 10/693,255, Examiner Interview Summary mailed Feb. 17, 2005”, 3 pgs. |
“U.S. Appl. No. 10/693,255, Non Final Office Action mailed Dec. 9, 2004”, 6 pgs. |
“U.S. Appl. No. 10/693,255, Notice of Allowance mailed Mar. 9, 2005”, 9 pgs. |
“U.S. Appl. No. 10/693,255, Response filed Feb. 17, 2005 to Non Final Office Action mailed Dec. 9, 2004”, 6 pgs. |
“U.S. Appl. No. 10/752,435, Final Office Action mailed May 14, 2010”, 8 pgs. |
“U.S. Appl. No. 10/752,435, Final Office Action mailed Jul. 12, 2007”, 8 pgs. |
“U.S. Appl. No. 10/752,435, Final Office Action mailed Dec. 8, 2008”, 8 pgs. |
“U.S. Appl. No. 10/752,435, Non Final Office Action mailed Mar. 18, 2008”, 7 pgs. |
“U.S. Appl. No. 10/752,435, Non Final Office Action mailed Jul. 21, 2009”, 7 pgs. |
“U.S. Appl. No. 10/752,435, Non Final Office Action mailed Oct. 19, 2006”, 17 pgs. |
“U.S. Appl. No. 11/166,411, Final Office Action mailed Dec. 3, 2009”, 5 pgs. |
“U.S. Appl. No. 11/166,428, Final Office Action mailed Jan. 12, 2009”, 10 pgs. |
“U.S. Appl. No. 11/166,428, Final Office Action mailed Mar. 16, 2010”, 8 pgs. |
“U.S. Appl. No. 11/166,428, Non Final Office Action mailed May 14, 2008”, 6 pgs. |
“U.S. Appl. No. 11/166,428, Non Final Office Action mailed Jun. 16, 2009”, 10 pgs. |
“U.S. Appl. No. 11/254,619, Response filed Apr. 1, 2010 to Non Final Office Action mailed Oct. 1, 2009”, 5 pgs. |
“U.S. Appl. No. 11/254,619, Response filed Apr. 20, 2012 to Final Office Action mailed Oct. 20, 2011”, 11 pgs. |
“U.S. Appl. No. 11/254,619, Response filed Aug. 3, 2011 to Non Final Office Action mailed Feb. 3, 2011”, 13 pgs. |
“U.S. Appl. No. 11/254,619, Response filed Dec. 29, 2010 to Final Office Action mailed Jun. 30, 2010”, 12 pgs. |
“U.S. Appl. No. 11/580,584, Appeal Brief filed Nov. 15, 2010”, 11 pgs. |
“U.S. Appl. No. 11/580,584, Final Office Action mailed Jan. 22, 2009”, 9 pgs. |
“U.S. Appl. No. 11/580,584, Final Office Action mailed Oct. 16, 2009”, 8 pgs. |
“U.S. Appl. No. 11/580,584, Non Final Office Action mailed Apr. 18, 2008”, 6 pgs. |
“U.S. Appl. No. 11/580,584, Notice of Allowance mailed Feb. 4, 2011”, 7 pgs. |
“U.S. Appl. No. 11/580,584, Response filed Jul. 22, 2009 to Final Office Action mailed Jan. 22, 2009”, 6 pgs. |
“U.S. Appl. No. 11/580,584, Response filed Oct. 20, 2008 to Non Final Office Action mailed Apr. 18, 2008”, 5 pgs. |
“U.S. Appl. No. 11/981,112, Final Office Action mailed Apr. 29, 2010”, 9 pgs. |
“U.S. Appl. No. 11/981,112, Non Final Office Action mailed Jul. 8, 2009”, 11 pgs. |
“U.S. Appl. No. 12/288,031, Non Final Office Action mailed May 10, 2012”, 8 pgs. |
“U.S. Appl. No. 12/288,031, Response filed Mar. 25, 2013 to Final Office Action mailed Jan. 3, 2013”, 11 pgs. |
“U.S. Appl. No. 12/288,031, Response filed Apr. 4, 2012 to Restriction Requirement mailed Nov. 4, 2011”, 3 pgs. |
“U.S. Appl. No. 12/288,031, Response filed Oct. 10, 2012 to Non Final Office Action mailed May 10, 2012”, 11 pgs. |
“U.S. Appl. No. 12/288,031, Restriction Requirement mailed Nov. 4, 2011”, 9 pgs. |
“U.S. Appl. No. 12/288,034, Non Final Office Action mailed Jun. 22, 2012”, 7 pgs. |
“U.S. Appl. No. 12/288,034, Response filed May 1, 2012 to Restriction Requirement mailed Nov. 3, 2011”, 4 pgs. |
“U.S. Appl. No. 12/288,034, Response filed Dec. 21, 2012 to Non Final Office Action mailed Jun. 22, 2012”, 12 pgs. |
“U.S. Appl. No. 12/288,034, Restriction Requirement mailed Nov. 3, 2011”, 9 pgs. |
“U.S. Appl. No. 12/315,015, Advisory Action mailed Sep. 12, 2012”, 3 pgs. |
“U.S. Appl. No. 12/315,015, Final Office Action mailed Apr. 26, 2012”, 7 pgs. |
“U.S. Appl. No. 12/315,015, Preliminary Amendment filed Mar 10, 2009”, 3 pgs. |
“U.S. Appl. No. 12/315,015, Response filed Apr. 6, 2012 to Non Final Office Action mailed Oct. 6, 2011”, 12 pgs. |
“U.S. Appl. No. 12/315,015, Response filed Aug. 27, 2012 to Final Office Action mailed Apr. 26, 2012”, 6 pgs. |
“U.S. Appl. No. 13/162,384, Preliminary Amendment filed Jun. 16, 2011”, 7 pgs. |
“U.S. Appl. No. 13/291,942, Preliminary Amendment filed Nov. 8, 2011”, 3 pgs. |
“U.S. Appl. No. 13/495,836, Non Final Office Action mailed Aug. 5, 2013”, 7 pgs. |
“U.S. Appl. No. 13/495,836, Preliminary Amendment filed Jun. 13, 2012”, 8 pgs. |
“U.S. Appl. No. 13/495,836, Response filed Mar. 25, 2013 to Non Final Office Action mailed Dec. 26, 2012”, 9 pgs. |
“Australian Application Serial No. 2002353807, First Examiner Report mailed Nov. 16, 2006”, 2 pgs. |
“Australian Application Serial No. 2004277897, First Examiner Report mailed Oct. 14, 2009”, 2 pgs. |
“Australian Application Serial No. 2004277897, Response filed Jul. 14, 2011 to First Examiner Report mailed Oct. 14, 2009”, 9 pgs. |
“Australian Application Serial No. 2005235108, Office Action mailed Feb. 26, 2010”, 3 pgs. |
“Australian Application Serial No. 2006305688, First Examiner Report mailed 03-10-11”, 3 pgs. |
“Australian Application Serial No. 2006305688, Response filed Oct. 22, 2012 to First Examiner Report mailed Mar. 10, 2011”, 16 pgs. |
“Australian Application Serial No. 2008243229, First Examiner Report mailed Apr. 13, 2010”, 2 pgs. |
“Australian Application Serial No. 2008243229, Response filed May 13, 2011 to Office Action mailed Apr. 13, 2010”, 15 pgs. |
“Australian Application Serial No. 2011253682, Response filed Jul. 17, 2013 to Office Action mailed Sep. 27, 2012”, 19 pgs. |
“Canadian Application Serial No. 2,539,585, Office Action mailed Sep. 19, 2012”, 2 pgs. |
“Canadian Application Serial No. 2,554,022, Office Action mailed Jun. 22, 2011”, 3 pgs. |
“Canadian Application Serial No. 2,554,022, Office Action mailed Aug. 31, 2010”, 2 pgs. |
“Canadian Application Serial No. 2,558,317, Office Action mailed Aug. 31, 2010”, 2 pgs. |
“Canadian Application Serial No. 2,558,317, Office Action mailed Sep. 28, 2011”, 3 pgs. |
“Chinese Application Serial No. 200480027649.7, Office Action mailed Jun. 23, 2008”, w/English translation, 5 pgs. |
“Chinese Application Serial No. 200480027649.7, Office Action mailed Sep. 4, 2009”, w/English translation, 18 pgs. |
“Chinese Application Serial No. 200480027649.7, Office Action mailed Dec. 24, 2010”, w/English translation, 6 pgs. |
“Chinese Application Serial No. 200480027649.7, Response filed Mar. 8, 2011 to Office Action mailed Dec. 24, 2010”, w/English translation, 7 pgs. |
“Chinese Application Serial No. 200580006169.7, Office Action mailed Mar. 1, 2010”, w/English translation, 12 pgs. |
“Chinese Application Serial No. 200580006169.7, Response filed Jul. 14, 2010 to Office Action mailed Mar. 1, 2010”, w/English translation, 32 pgs. |
“Chinese Application Serial No. 200680034052.4, Office Action mailed May 11, 2010”, w/English translation, 7 pgs. |
“Chinese Application Serial No. 200680034052.4, Office Action mailed Aug. 14, 2009”, w/English translation, 13 pgs. |
“Chinese Application Serial No. 200910139527.1, Office Action mailed Jul. 12, 2010”, w/English translation, 9 pgs. |
“European Application Serial No. 04788653.6, Office Action mailed May 19, 2006”, 2 pgs. |
“European Application Serial No. 05713941.2, Office Action mailed Dec. 13, 2007”, 2 pgs. |
“European Application Serial No. 06802573.3, Extended European Search Report mailed Feb. 15, 2012”, 6 pgs. |
“European Application Serial No. 06802573.3, Office Action mailed Mar. 5, 2012”, 1 pg. |
“European Application Serial No. 06802573.3, Office Action mailed May 28, 2008”, 2 pgs. |
“European Application Serial No. 06802573.3, Response filed Sep. 3, 2012 to Office Action mailed Mar. 5, 2012”, 15 pgs. |
“European Application Serial No. 06802580.8, Office Action mailed Feb. 25, 2013”, 3 pgs. |
“European Application Serial No. 09075319.5, Extended European Search Report mailed Oct. 14, 2009”, 6 pgs. |
“European Application Serial No. 09075319.5, Office Action mailed Jan. 14, 2010”, 1 pgs. |
“European Application Serial No. 09075319.5, Office Action mailed Oct. 14, 2010”, 4 pgs. |
“European Application Serial No. 09820886.1, Office Action mailed Jun. 7, 2011”, 2 pgs. |
“European Application Serial No. 09820886.1, Response filed Dec. 8, 2011 to Office Action mailed Jun. 7, 2011”, 3 pgs. |
“European Application Serial No. 09820891.1, Office Action mailed Jun. 7, 2011”, 2 pgs. |
“European Application Serial No. 09820891.1, Response filed Dec. 8, 2011 to Office Action mailed Jun. 7, 2011”, 2 pgs. |
“European Application Serial No. 09075319.5, Response filed Feb. 21, 2011 to Office Action mailed Oct. 14, 2010”, 5 pgs. |
“European Application Serial No. 09075319.5, Response filed Jul. 20, 2010 to Office Action mailed Jan. 14, 2010”, 13 pgs. |
“International Application Serial No. PCT/US2002/038365, International Preliminary Examination Report mailed May 8, 2003”, 3 pgs. |
“International Application Serial No. PCT/US2004/027589, International Preliminary Report on Patentability mailed Apr. 6, 2005”, 4 pgs. |
“International Application Serial No. PCT/US2004/027589, International Search Report mailed Apr. 6, 2005”, 1 pg. |
“International Application Serial No. PCT/US2004/027589, Written Opinion mailed Apr. 6, 2005”, 3 pgs. |
“International Application Serial No. PCT/US2004/027590, International Preliminary Examination Report mailed Feb. 16, 2006”, 3 pgs. |
“International Application Serial No. PCT/US2004/027590, International Search Report mailed Jan. 12, 2005”, 1 pg. |
“International Application Serial No. PCT/US2004/027590, Written Opinion mailed Jan. 12, 2005”, 3 pgs. |
“International Application Serial No. PCT/US2005/000059, International Preliminary Report on Patentability mailed May 18, 2007”, 8 pgs. |
“International Application Serial No. PCT/US2005/000059, International Search Report mailed Jan. 5, 2007”, 3 pgs. |
“International Application Serial No. PCT/US2005/000059, Written Opinion mailed Jan. 5, 2007”, 8 pgs. |
“International Application Serial No. PCT/US2006/033747, International Preliminary Report on Patentability mailed Mar. 1, 2011”, 4 pgs. |
“International Application Serial No. PCT/US2006/033748, International Preliminary Report on Patentability mailed Jun. 18, 2008”, 7 pgs. |
“International Application Serial No. PCT/US2006/033748, International Search Report mailed Aug. 15, 2007”, 1 pg. |
“International Application Serial No. PCT/US2006/033748, Written Opinion mailed Aug. 15, 2007”, 5 pgs. |
“International Application Serial No. PCT/US2006/037085, International Preliminary Report on Patentability mailed Aug. 20, 2007”, 10 pgs. |
“International Application Serial No. PCT/US2009/005604, International Preliminary Report on Patentability mailed Jan. 13, 2011”, 10 pgs. |
“International Application Serial No. PCT/US2009/005607, International Preliminary Report on Patentability mailed Jan. 9, 2011”, 9 pgs. |
“International Application Serial No. PCT/US2009/005607, International Search Report mailed Dec. 11, 2009”, 2 pgs. |
“International Application Serial No. PCT/US2009/005607, Written Opinion mailed Dec. 11, 2009”, 6 pgs. |
“International Application Serial No. PCT/US2009/005608, International Preliminary Report on Patentability mailed Jan. 14, 2011”, 7 pgs. |
“International Application Serial No. PCT/US2009/005608, International Search Report mailed Dec. 10, 2009”, 2 pgs. |
“International Application Serial No. PCT/US2009/005608, Written Opinion mailed Dec. 10, 2009”, 4 pgs. |
“International Application Serial No. PCT/US2009/005609, International Preliminary Report on Patentability mailed Jan. 9, 2011”, 9 pgs. |
“Japanese Application Serial No. 2003-546789, Office Action mailed Feb. 26, 2009”, w/English translation, 7 pgs. |
“Japanese Application Serial No. 2003-546789, Office Action mailed Jun. 17, 2008”, w/English translation, 6 pgs. |
“Japanese Application Serial No. 2003-546789, Response filed Dec. 11, 2008 to Office Action mailed Jun. 17, 2008”, w/English translation, 9 pgs. |
“Japanese Application Serial No. 2006-528036, Office Action mailed Feb. 26, 2009”, w/English translation, 5 pgs. |
“Japanese Application Serial No. 2006-528036, Office Action mailed Jun. 23, 2008”, w/English translation, 5 pgs. |
“Japanese Application Serial No. 2006-528036, Response filed Dec. 25, 2008 to Office Action mailed Jun. 23, 2008”, w/English translation, 9 pgs. |
“Japanese Application Serial No. 2007500928, Office Action mailed Jul. 1, 2010”, w/English translation, 10 pgs. |
“Japanese Application Serial No. 2007504965, Office Action mailed Mar. 7, 2012”, w/English translation, 4 pgs. |
“Japanese Application Serial No. 2007504965, Office Action mailed Jun. 14, 2011”, w/English translation, 4 pgs. |
“Japanese Application Serial No. 2007504965, Office Action mailed Sep. 14, 2010”, English translation, 1 pg. |
“Japanese Application Serial No. 2008-536577, Office Action mailed Jul. 8, 2011”, w/English translation, 4 pgs. |
“U.S. Appl. No. 10/307,226, 312 Amendment filed Oct. 24, 2011”, 3 pgs. |
“U.S. Appl. No. 10/307,226, Appeal Brief filed Oct. 14, 2010”, 15 pgs. |
“U.S. Appl. No. 10/307,226, Final Office Action mailed Jun. 27, 2008”, 6 pgs. |
“U.S. Appl. No. 10/307,226, Final Office Action mailed Dec. 12, 2006”, 5 pgs. |
“U.S. Appl. No. 10/307,226, Non Final Office Action mailed Mar. 13, 2006”, 6 pgs. |
“U.S. Appl. No. 10/307,226, Non Final Office Action mailed Jun. 12, 2007”, 5 pgs. |
“U.S. Appl. No. 10/307,226, Non Final Office Action mailed Sep. 9, 2009”, 16 pgs. |
“U.S. Appl. No. 10/307,226, Notice of Allowance mailed Jul. 22, 2011”, 8 pgs. |
“U.S. Appl. No. 10/307,226, Preliminary Amendment filed Jul. 22, 2005”, 3 pgs. |
“U.S. Appl. No. 10/307,226, PTO Response to 312 Amendment mailed Nov. 10, 2011”, 3 pgs. |
“U.S. Appl. No. 10/307,226, Response filed Apr. 9, 2007 to Final Office Action mailed Dec. 12, 2006”, 7 pgs. |
“U.S. Appl. No. 10/307,226, Response filed Jun. 23, 2009 to Final Office Action mailed Jun. 27, 2008”, 10 pgs. |
“U.S. Appl. No. 10/307,226, Response filed Sep. 15, 2006 to Non Final Office Action mailed Mar. 13, 2006”, 6 pgs. |
“U.S. Appl. No. 10/307,226, Response filed Dec. 14, 2007 to Non Final Office Action mailed Jun. 12, 2007”, 7 pgs. |
“U.S. Appl. No. 10/669,881, Preliminary Amendment May 6, 2005”, 3 pgs. |
“U.S. Appl. No. 10/669,881, Response filed Mar. 11, 2008 to Final Office Action mailed Jan. 25, 2008”, 8 pgs. |
“U.S. Appl. No. 10/669,881, Response filed May 15, 2006 to Non Final Office Action mailed Jan. 27, 2006”, 9 pgs. |
“U.S. Appl. No. 10/669,881, Response filed Sep. 7, 2007 to Restriction Requirement mailed Jun. 19, 2007”, 4 pgs. |
“U.S. Appl. No. 10/669,881, Response filed Oct. 2, 2006 to Restriction Requirement mailed Jul. 27, 2006”, 6 pgs. |
“U.S. Appl. No. 10/669,881, Restriction Requirement Jul. 27, 2006”, 5 pgs. |
“U.S. Appl. No. 10/669,881, Restriction Requirement mailed Jun. 19, 2007”, 5 pgs. |
“U.S. Appl. No. 10/752,435, Response filed Jan. 9, 2008 to Final Office Action mailed Jul. 12, 2007”, 10 pgs. |
“U.S. Appl. No. 10/752,435, Response filed Jan. 25, 2010 to Non Final Office Action mailed Jul. 21, 2009”, 9 pgs. |
“U.S. Appl. No. 10/752,435, Response filed Apr. 9, 2007 to Non Final Office Action mailed Oct. 19, 2006”, 13 pgs. |
“U.S. Appl. No. 10/752,435, Response filed May 12, 2009 to Final Office Action mailed Dec. 8, 2008”, 9 pgs. |
“U.S. Appl. No. 10/752,435, Response filed Sep. 19, 2008 to Non Final Office Action mailed Mar. 18, 2008”, 7 pgs. |
“U.S. Appl. No. 10/786,465, Supplemental Amendment filed Mar. 18, 2008”, 8 pgs. |
“U.S. Appl. No. 10/808,216, Preliminary Amendment filed Jun. 15, 2005”, 3 pgs. |
“U.S. Appl. No. 11/166,428, Response filed May 12, 2009 to Final Office Action mailed Jan. 12, 2009”, 6 pgs. |
“U.S. Appl. No. 11/166,428, Response filed Nov. 17, 2008 to Non Final Office Action mailed May 14, 2008”, 6 pgs. |
“U.S. Appl. No. 11/166,428, Response filed Dec. 22, 2009 to Non Final Office Action mailed Dec. 16, 2009”, 8 pgs. |
“U.S. Appl. No. 11/365,056, Final Office Action mailed Dec. 9, 2010”, 13 pgs. |
“U.S. Appl. No. 11/365,056, Non Final Office Action mailed Mar. 23, 2010”, 11 pgs. |
“U.S. Appl. No. 11/365,056, Response filed Sep. 28, 2010 to Non Final Office Action mailed Mar. 23, 2010”, 5 pgs. |
“U.S. Appl. No. 11/365,056, Response filed Dec. 10, 2009 to Restriction Requirement mailed Jun. 10, 2009”, 44 pgs. |
“U.S. Appl. No. 11/365,056, Restriction Requirement mailed Jun. 10, 2009”, 5 pgs. |
“U.S. Appl. No. 11/540,428, Response filed May 12, 2011 to Non Final Office Action mailed Nov. 12, 2010”, 12 pgs. |
“U.S. Appl. No. 11/540,428, Response filed Oct. 1, 2010 to Restriction Requirement mailed Mar. 29, 2010”, 6 pgs. |
“U.S. Appl. No. 11/540,428, Restriction Requirement mailed Mar. 29, 2010”, 9 pgs. |
“U.S. Appl. No. 11/633,724, Final Office Action mailed Jun. 22, 2010”, 6 pgs. |
“U.S. Appl. No. 11/633,724, Response filed Jun. 8, 2010 to Final Office Action mailed Dec. 8, 2009”, 4 pgs. |
“U.S. Appl. No. 11/978,753, Response filed Mar. 3, 2011 to Non Final Office Action mailed Sep. 3, 2010”, 9 pgs. |
“U.S. Appl. No. 11/981,112, Final Office Action mailed Oct. 8, 2013”, 9 pgs. |
“U.S. Appl. No. 11/981,112, Response filed Jan. 6, 2010 to Non Final Office Action mailed Jul. 8, 2009”, 7 pgs. |
“U.S. Appl. No. 11/981,112, Response filed Nov. 1, 2010 to Final Office Action mailed Apr. 29, 2010”, 7 pgs. |
“U.S. Appl. No. 12/288,032, Restriction Requirement mailed Nov. 4, 2011”, 9 pgs. |
“U.S. Appl. No. 12/288,045, Restriction Requirement mailed Nov. 16, 2011”, 9 pgs. |
“U.S. Appl. No. 12/315,015, Non Final Office Action mailed Sep. 27, 2013”, 7 pgs. |
“U.S. Appl. No. 12/942,232, Non Final Office Action mailed Oct. 9, 2013”, 13 pgs. |
“U.S. Appl. No. 13/157,242, Non Final Office Action mailed Oct. 31, 2013”, 6 pgs. |
“U.S. Appl. No. 13/162,384, Final Office Action mailed Aug. 27, 2013”, 14 pgs. |
“U.S. Appl. No. 13/162,384, Response filed Oct. 18, 2013 to Final Office Action mailed Aug. 27, 2013”, 5 pgs. |
“Australian Application Serial No. 2002351188, Office Action mailed Mar. 30, 2007”, 1 pg. |
“Australian Application Serial No. 2002351188, Office Action mailed Dec. 8, 2008”, 3 pgs. |
“Australian Application Serial No. 2004287354, Office Action mailed Oct. 13, 2009”, 2 pgs. |
“Australian Application Serial No. 2004287355, Office Action mailed May 11, 2009”, 2 pgs. |
“Australian Application Serial No. 2005204615, Office Action mailed Jan. 20, 2010”, 4 pgs. |
“Australian Application Serial No. 2006302908, Office Action mailed Mar. 4, 2011”, 8 pgs. |
“Australian Application Serial No. 2006305689, Office Action mailed Sep. 5, 2011”, 3 pgs. |
“Australian Application Serial No. 2006309241, Office Action mailed Mar. 4, 2011”, 6 pgs. |
“Canadian Application Serial No. 2,464,900, Office Action mailed Sep. 29, 2009”, 3 pgs. |
“Canadian Application Serial No. 2,539,585, Office Action mailed Aug. 31, 2010”, 2 pgs. |
“Canadian Application Serial No. 2,546,681, Office Action mailed Feb. 25, 2011”, 3 pgs. |
“Canadian Application Serial No. 2,546,721, Office Action mailed Feb. 25, 2011”, 3 pgs. |
“Canadian Application Serial No. 2,551,685, Office Action mailed Jan. 17, 2011”, 3 pgs. |
“Canadian Application Serial No. 02823581.9, Office Action mailed Mar. 1, 2006”, 7 pgs. |
“Canadian Application Serial No. 02823581.9, Office Action mailed Apr. 18, 2008”, 6 pgs. |
“Canadian Application Serial No. 02823581.9, Office Action mailed Aug. 8, 2007”, 4 pgs. |
“Canadian Application Serial No. 02823581.9, Office Action mailed Nov. 17, 2006”, 7 pgs. |
“Chinese Application Serial No. 02823581.9, Response filed Jan. 31, 2007 to Office Action mailed Nov. 17, 2006”, 8 pgs. |
“Chinese Application Serial No. 02823581.9, Response filed Apr. 7, 2006 to Office Action mailed Mar. 1, 2006”, 4 pgs. |
“Chinese Application Serial No. 02823581.9, Response filed May 19, 2008 to Office Action mailed Apr. 18, 2008”, (W/English Translation), 38 pgs. |
“Chinese Application Serial No. 02823581.9, Response filed Dec. 3, 2007 to Office Action mailed Aug. 8, 2007”, 6 pgs. |
“Chinese Application Serial No. 200480027649.7, Response filed Jan. 19, 2010 to Office Action mailed Sep. 4, 2009”, 5 pgs. |
“Chinese Application Serial No. 200480031226.2, Office Action mailed Jan. 23, 2009”, 9 pgs. |
“Chinese Application Serial No. 200480031226.2, Office Action mailed Apr. 27, 2010”, (W/English Translation), 7 pgs. |
“Chinese Application Serial No. 200480031226.2, Office Action mailed Dec. 21, 2010”, (W/English Translation), 10 pgs. |
“Chinese Application Serial No. 200480031226.2, Response filed Feb. 25, 2011 to Office Action mailed Dec. 21, 2010”, (W/English Translation), 18 pgs. |
“Chinese Application Serial No. 200480031226.2, Response filed May 22, 2009 to Office Action mailed Jan. 23, 2009”, 5 pgs. |
“Chinese Application Serial No. 200480031226.2, Response filed Jul. 12, 2010 to Office Action mailed Apr. 27, 2010”, 5 pgs. |
“Chinese Application Serial No. 200580002026.9, Office Action mailed Jun. 19, 2009”, (W/English Translation), 12 pgs. |
“Chinese Application Serial No. 200580002026.9, Response filed Jan. 4, 2010 to Office Action mailed Jun. 19, 2009”, 10 pgs. |
“Chinese Application Serial No. 200580009570.6, Office Action mailed May 9, 2008”, (W/English Translation), 2 pgs. |
“Chinese Application Serial No. 200580009570.6, Response filed Nov. 21, 2008 to Office Action mailed May 9, 2008”, 7 pgs. |
“Chinese Application Serial No. 200680034052.4, Response filed Mar. 1, 2010 to Office Action mailed Aug. 14, 2009”, 4 pgs. |
“Chinese Application Serial No. 200680034052.4, Response filed Sep. 26, 2010 to Office Action mailed May 11, 2010”, 5 pgs. |
“Chinese Application Serial No. 200680038882.4, Office Action mailed May 11, 2010”, (W/English Translation), 18 pgs. |
“Chinese Application Serial No. 200680046854.7, Office Action mailed Apr. 14, 2010”, (W/English Translation), 18 pgs. |
“Chinese Application Serial No. 200680046854.7, Response filed Sep. 26, 2010 to Office Action mailed Apr. 14, 2010”, 10 pgs. |
“Chinese Application Serial No. 200680047552.1, Office Action mailed Jun. 4, 2010”, (W/English Translation), 7 pgs. |
“Chinese Application Serial No. 200680047552.1, Response filed Dec. 20, 2010 to Office Action mailed Jun. 4, 2010”, 10 pgs. |
“Chinese Application Serial No. 200810210922.X, Office Action mailed Jan. 19, 2012”, (W/English Translation), 6 pgs. |
“Chinese Application Serial No. 200810210922.X, Office Action mailed Apr. 2, 2010”, (W/English Translation), 4 pgs. |
“Chinese Application Serial No. 200810210922.X, Office Action mailed Aug. 23, 2011”, 6 pgs. |
“Chinese Application Serial No. 200810210922.X, Response filed Jun. 1, 2012 to Office Action mailed Jan. 19, 2012”, 5 pgs. |
“Chinese Application Serial No. 200810210922.X, Response filed Aug. 12, 2010 to Office Action mailed Apr. 2, 2010”, 10 pgs. |
“Chinese Application Serial No. 200910139527.1, Response filed Nov. 28, 2011 to Office Action mailed Jul. 12, 2010”, 9 pgs. |
“European Application Serial No. 02789196.9, European Search Report mailed Aug. 14, 2009”, 5 pgs. |
“European Application Serial No. 02789196.9, Office Action mailed Feb. 6, 2012”, 4 pgs. |
“European Application Serial No. 02789196.9, Office Action mailed Mar. 7, 2012”, 3 pgs. |
“European Application Serial No. 02789196.9, Office Action mailed Apr. 19, 2010”, 4 pgs. |
“European Application Serial No. 02789196.9, Office Action mailed Jul. 14, 2011”, 3 pgs. |
“European Application Serial No. 02789196.9, Response filed Jan. 18, 2012 to Office Action mailed Jul.14, 2011”, 19 pgs. |
“European Application Serial No. 02789196.9, Response filed Feb. 16, 2012 to Office Action mailed Feb. 6, 2012”, 9 pgs. |
“European Application Serial No. 02789196.9, Response filed Apr. 5, 2012 to Office Action mailed Mar. 7, 2012”, 5 pgs. |
“European Application Serial No. 02789196.9, Response filed Oct. 25, 2010 to Office Action mailed Apr. 19, 2010”, 16 pgs. |
“European Application Serial No. 05704902.5, European Search Report mailed Aug. 29, 2011”, 3 pgs. |
“European Application Serial No. 06802578.2, European Search Report mailed Mar. 7, 2013”, 10 pgs. |
“German Application Serial No. 10297483.7, Office Action mailed Jan. 9, 2006”, 4 pgs. |
“German Application Serial No. 10297483.7, Office Action mailed Jul. 8, 2006”, 2 pgs. |
“German Application Serial No. 10297483.7, Office Action mailed and Response filed Oct. 30, 2006”, 8 pgs. |
“German Application Serial No. 10297483.7, Response filed Jul. 7, 2006 to Office Action mailed Jan. 9, 2006”, 14 pgs. |
“German Application Serial No. 10297483.7, Response filed Oct. 26, 2006 to Office Action mailed Jul. 8, 2006”, 3 pgs. |
“Great Britain Application Serial No. 0411107.6, Office Action mailed Feb. 28, 2005”, 3 pgs. |
“Great Britain Application Serial No. 0411107.6, Office Action mailed Sep. 29, 2005”, 1 pg. |
“Great Britain Application Serial No. 0411107.6, Response filed Aug. 23, 2005 to Office Action mailed Feb. 28, 2005”, 3 pgs. |
“Great Britain Application Serial No. 0411107.6, Response filed Oct. 31, 2005 to Office Action mailed Sep. 29, 2005”, 4 pgs. |
“Great Britain Application Serial No. 0522152.8, Office Action mailed Dec. 5, 2005”, 5 pgs. |
“Great Britain Application Serial No. 0522152.8, Response filed Apr. 26, 2006 to Office Action mailed Dec. 5, 2005”, 48 pgs. |
“International Application Serial No. PCT/US2002/032753, International Preliminary Examination Report mailed Aug. 16, 2004”, 3 pgs. |
“International Application Serial No. PCT/US2002/032753, International Search Report mailed Mar. 6, 2003”, 1 pg. |
“International Application Serial No. PCT/US2005/005453, International Preliminary Report on Patentability mailed Feb. 16, 2006”, 3 pgs. |
“International Application Serial No. PCT/US2005/005453, International Search Report mailed Aug. 30, 2005”, 1 pg. |
“International Application Serial No. PCT/US2005/005453, International Written Opinion mailed Aug. 30, 2005”, 3 pgs. |
“Japanese Application Serial No. 2003-546789, Office Action mailed Oct. 7, 2009”, 3 pgs. |
“Japanese Application Serial No. 2003-546789, Response filed May 21, 2009 to Office Action mailed Feb. 26, 2009”, 6 pgs. |
“Japanese Application Serial No. 2006-528036, Office Action mailed Jan. 19, 2010”, 3 pgs. |
“Japanese Application Serial No. 2006-536616, Office Action mailed Jun. 23, 2008”, (W/English Translation), 8 pgs. |
“Japanese Application Serial No. 2006-536616, Response filed Dec. 19, 2008 to Office Action mailed Jun. 23, 2008”, (W/English Translation), 9 pgs. |
“Japanese Application Serial No. 2006-536617, Office Action mailed Jun. 17, 2008”, (W/English Translation), 3 pgs. |
“Japanese Application Serial No. 2006-536617, Response filed May 12, 2009 to Office Action mailed Jun. 17, 2008”, (W/English Translation), 19 pgs. |
“Japanese Application Serial No. 2006-547608, Office Action mailed Jun. 23, 2008”, (W/English Translation), 5 pgs. |
“Japanese Application Serial No. 2006-547608, Respone filed Dec. 19, 2008 to Office Action mailed Jun. 23, 2008”, (W/English Translation), 10 pgs. |
“Japanese Application Serial No. 2007504965, Response filed Mar. 11, 2011 to Office Action mailed Sep. 14, 2010”, 8 pgs. |
“Japanese Application Serial No. 2008-306790, Office Action mailed May 31, 2011”, 1 pg. |
“Japanese Application Serial No. 2008-306790, Response filed Nov. 29, 2011 to Office Action mailed May 8, 2012”, 2 pgs. |
“Japanese Application Serial No. 2008-306790, Response filed Nov. 9, 2011 to Office Action mailed May 31, 2011”, (W/English Translation), 12 pgs. |
“Japanese Application Serial No. 2008-316282, Office Action mailed May 16, 2011”, 2 pgs. |
“Japanese Application Serial No. 2008-316296, Office Action mailed Feb. 28, 2011”, 2 pgs. |
“Japanese Application Serial No. 2008-316296, Office Action mailed Jun. 22, 2010”, 2 pgs. |
“Japanese Application Serial No. 2008-323279, Office Action mailed Sep. 30, 2010”, 1 pg. |
“Japanese Application Serial No. 2008-323290, Office Action mailed Jun. 6, 2012”, (W/English Translation), 8 pgs. |
“Japanese Application Serial No. 2008-323290, Office Action mailed Jun. 8, 2011”, (W/English Translation), 8 pgs. |
“Japanese Application Serial No. 2008-323290, Response filed Dec. 7, 2011 to Office Action mailed Jun. 8, 2011”, (W/English Translation), 16 pgs. |
“Japanese Application Serial No. 2008-536574, Office Action mailed Mar. 11, 2010”, (W/English Translation), 4 pgs. |
“Japanese Application Serial No. 2008-536574, Office Action mailed Oct. 3, 2011”, (W/English Translation), 7 pgs. |
“Japanese Application Serial No. 2008-536575, Office Action mailed Jul. 7, 2011”, (W/English Translation), 5 pgs. |
“Japanese Application Serial No. 2008-536576, Office Action mailed Jul. 19, 2011”, (W/English Translation), 4 pgs. |
“Japanese Application Serial No. 2008-536577, Notice of Allowance mailed May 30, 2012”, 3 pgs. |
“Japanese Application Serial No. 2008-536577, Response filed Jan. 6, 2012 to Office Action mailed Jul. 8, 2011”, (W/English Translation), 3 pgs. |
“U.S. Appl. No. 12/288,034, Final Office Action mailed Nov. 4, 2013”, 8 pgs. |
“U.S. Appl. No. 13/495,836, Response filed Nov. 5, 2013 to Non Final Office Action mailed Aug. 5, 2013”, 8 pgs. |
Number | Date | Country | |
---|---|---|---|
20110276062 A1 | Nov 2011 | US |
Number | Date | Country | |
---|---|---|---|
60488753 | Jul 2003 | US | |
60489011 | Jul 2003 | US | |
60333937 | Nov 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11254950 | Oct 2005 | US |
Child | 12917842 | US | |
Parent | 10271334 | Oct 2002 | US |
Child | 11166411 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11254619 | Oct 2005 | US |
Child | 11254950 | US | |
Parent | 10692283 | Oct 2003 | US |
Child | 11254619 | US | |
Parent | 10786465 | Feb 2004 | US |
Child | 11254950 | US | |
Parent | 10693255 | Oct 2003 | US |
Child | 10786465 | US | |
Parent | 10307226 | Nov 2002 | US |
Child | 11254950 | US | |
Parent | 10669881 | Sep 2003 | US |
Child | 10307226 | US | |
Parent | 11166411 | Jun 2005 | US |
Child | 10669881 | US |